US20020026185A1 - Cell necrosis apparatus - Google Patents

Cell necrosis apparatus Download PDF

Info

Publication number
US20020026185A1
US20020026185A1 US09/376,757 US37675799A US2002026185A1 US 20020026185 A1 US20020026185 A1 US 20020026185A1 US 37675799 A US37675799 A US 37675799A US 2002026185 A1 US2002026185 A1 US 2002026185A1
Authority
US
United States
Prior art keywords
introducer
energy delivery
cell necrosis
tissue
coupled
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US09/376,757
Inventor
Edward J. Gough
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rita Medical Systems Inc
Original Assignee
Edward J. Gough
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/515,379 external-priority patent/US5683384A/en
Priority claimed from US08/605,323 external-priority patent/US5728143A/en
Priority claimed from US08/963,239 external-priority patent/US6958062B1/en
Priority claimed from US09/020,182 external-priority patent/US6132425A/en
Application filed by Edward J. Gough filed Critical Edward J. Gough
Priority to US09/376,757 priority Critical patent/US20020026185A1/en
Publication of US20020026185A1 publication Critical patent/US20020026185A1/en
Assigned to RITA MEDICAL SYSTEMS, INC. reassignment RITA MEDICAL SYSTEMS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: EDWARDS, STUART D.
Abandoned legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/06—Electrodes for high-frequency therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14—Probes or electrodes therefor
    • A61B18/1477—Needle-like probes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14—Probes or electrodes therefor
    • A61B18/1482—Probes or electrodes therefor having a long rigid shaft for accessing the inner body transcutaneously in minimal invasive surgery, e.g. laparoscopy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • A61B18/1815—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using microwaves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/40—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals
    • A61N1/403—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals for thermotherapy, e.g. hyperthermia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14—Probes or electrodes therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14—Probes or electrodes therefor
    • A61B18/1402—Probes for open surgery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14—Probes or electrodes therefor
    • A61B18/1485—Probes or electrodes therefor having a short rigid shaft for accessing the inner body through natural openings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14—Probes or electrodes therefor
    • A61B18/1492—Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00017—Electrical control of surgical instruments
    • A61B2017/00022—Sensing or detecting at the treatment site
    • A61B2017/00084—Temperature
    • A61B2017/00101—Temperature using an array of thermosensors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00005—Cooling or heating of the probe or tissue immediately surrounding the probe
    • A61B2018/00011—Cooling or heating of the probe or tissue immediately surrounding the probe with fluids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00005—Cooling or heating of the probe or tissue immediately surrounding the probe
    • A61B2018/00011—Cooling or heating of the probe or tissue immediately surrounding the probe with fluids
    • A61B2018/00023—Cooling or heating of the probe or tissue immediately surrounding the probe with fluids closed, i.e. without wound contact by the fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00053—Mechanical features of the instrument of device
    • A61B2018/00184—Moving parts
    • A61B2018/00196—Moving parts reciprocating lengthwise
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00053—Mechanical features of the instrument of device
    • A61B2018/00273—Anchoring means for temporary attachment of a device to tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00452—Skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00452—Skin
    • A61B2018/00476—Hair follicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00571—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
    • A61B2018/00577—Ablation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636—Sensing and controlling the application of energy
    • A61B2018/00666—Sensing and controlling the application of energy using a threshold value
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636—Sensing and controlling the application of energy
    • A61B2018/00666—Sensing and controlling the application of energy using a threshold value
    • A61B2018/00678—Sensing and controlling the application of energy using a threshold value upper
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636—Sensing and controlling the application of energy
    • A61B2018/00696—Controlled or regulated parameters
    • A61B2018/00702—Power or energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636—Sensing and controlling the application of energy
    • A61B2018/00696—Controlled or regulated parameters
    • A61B2018/00702—Power or energy
    • A61B2018/00708—Power or energy switching the power on or off
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636—Sensing and controlling the application of energy
    • A61B2018/00696—Controlled or regulated parameters
    • A61B2018/00744—Fluid flow
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636—Sensing and controlling the application of energy
    • A61B2018/00773—Sensed parameters
    • A61B2018/00779—Power or energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636—Sensing and controlling the application of energy
    • A61B2018/00773—Sensed parameters
    • A61B2018/00791—Temperature
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636—Sensing and controlling the application of energy
    • A61B2018/00773—Sensed parameters
    • A61B2018/00791—Temperature
    • A61B2018/00797—Temperature measured by multiple temperature sensors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636—Sensing and controlling the application of energy
    • A61B2018/00773—Sensed parameters
    • A61B2018/00827—Current
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636—Sensing and controlling the application of energy
    • A61B2018/00773—Sensed parameters
    • A61B2018/00875—Resistance or impedance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636—Sensing and controlling the application of energy
    • A61B2018/00773—Sensed parameters
    • A61B2018/00892—Voltage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/1206—Generators therefor
    • A61B2018/124—Generators therefor switching the output to different electrodes, e.g. sequentially
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/1206—Generators therefor
    • A61B2018/1246—Generators therefor characterised by the output polarity
    • A61B2018/1253—Generators therefor characterised by the output polarity monopolar
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/1206—Generators therefor
    • A61B2018/1246—Generators therefor characterised by the output polarity
    • A61B2018/126—Generators therefor characterised by the output polarity bipolar
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14—Probes or electrodes therefor
    • A61B2018/1405—Electrodes having a specific shape
    • A61B2018/1425—Needle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14—Probes or electrodes therefor
    • A61B2018/1405—Electrodes having a specific shape
    • A61B2018/1425—Needle
    • A61B2018/143—Needle multiple needles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14—Probes or electrodes therefor
    • A61B2018/1405—Electrodes having a specific shape
    • A61B2018/1425—Needle
    • A61B2018/1432—Needle curved
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14—Probes or electrodes therefor
    • A61B2018/1405—Electrodes having a specific shape
    • A61B2018/1435—Spiral
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14—Probes or electrodes therefor
    • A61B2018/1472—Probes or electrodes therefor for use with liquid electrolyte, e.g. virtual electrodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2218/00—Details of surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2218/001—Details of surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body having means for irrigation and/or aspiration of substances to and/or from the surgical site
    • A61B2218/002—Irrigation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
    • A61M25/0068—Static characteristics of the catheter tip, e.g. shape, atraumatic tip, curved tip or tip structure
    • A61M25/007—Side holes, e.g. their profiles or arrangements; Provisions to keep side holes unblocked
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M3/00—Medical syringes, e.g. enemata; Irrigators
    • A61M3/02—Enemata; Irrigators
    • A61M3/0279—Cannula; Nozzles; Tips; their connection means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/02—Radiation therapy using microwaves
    • A61N5/04—Radiators for near-field treatment

Definitions

  • This invention relates generally to a cell necrosis apparatus, and more particularly to a cell necrosis apparatus with a flexible introducer.
  • Examples illustrating the use of electromagnetic energy to ablate tissue are disclosed in: U.S. Pat. No. 4,562,200; U.S. Pat. No. 4,411,266; U.S. Pat. No. 4,838,265; U.S. Pat. No. 5,403,311; U.S. Pat. No. 4,011,872; U.S. Pat. No. 5,385, 544; and U.S. Pat. No. 5,385,544.
  • an object of the invention is to provide a cell necrosis apparatus that provides tissue reduction at selected anatomical sites.
  • Another object of the invention is to provide a treatment apparatus to create cell necrosis.
  • Another object of the invention is to provide a cell necrosis apparatus with a flexible introducer.
  • Still another object of the invention is to provide a cell necrosis apparatus with an introducer that is flexible enough to come back upon itself.
  • a further object of the invention is to provide a cell necrosis apparatus with an introducer that is configured to be advanceable through or around a selected target cell necrosis mass, and be flexibly positioned at any desired site in tissue.
  • a cell necrosis apparatus with a flexible introducer including a lumen and a distal end sufficiently sharp to penetrate tissue.
  • An energy delivery device is positionable in the introducer as the introducer is advanced through tissue.
  • the energy delivery device includes a first RF electrode with a tissue piercing distal portion and a second RF electrode with a tissue piercing distal portion.
  • the first and second RF electrodes are deployable with curvature from the introducer at a selected tissue site in a lateral direction away from the periphery of the introducer.
  • the cell necrosis apparatus has a flexible introducer.
  • the energy delivery device includes a first RF electrode with a tissue piercing distal portion, a second RF electrode with a tissue piercing distal portion and a third RF electrode with a tissue piercing distal portion.
  • the first, second and third RF electrodes are positionable in the introducer as the introducer is advanced through tissue and deployable with curvature in a radially divergent configuration when extended beyond the introducer.
  • FIG. 1 is a perspective view of the cell necrosis apparatus of the present invention illustrating a flexible introducer and three laterally deployed energy delivery devices.
  • FIG. 2 is a perspective view of a conic geometric ablation achieved with the apparatus of FIG. 1.
  • FIG. 3 is a perspective view of the cell necrosis apparatus of the present invention with two energy delivery devices.
  • FIG. 4 is a perspective view illustrating three energy delivery devices creating a complete cell necrosis volume.
  • FIG. 5 is a perspective view illustrating the positioning of the cell necrosis apparatus in the center of a selected tissue mass, and the creation of a cylindrical ablation.
  • FIG. 6( a ) is a perspective view of the cell necrosis of the present invention illustrating two energy delivery devices which provide a retaining and gripping function.
  • FIG. 6( b ) is a perspective view of the cell necrosis apparatus of the present invention illustrating three secondary energy delivery devices which provide a retaining and gripping function.
  • FIG. 6( c ) is a cross-sectional view of the apparatus of FIG. 6( b ) taken along the lines 6 ( c )- 6 ( c ).
  • FIG. 7 is a perspective view of the cell necrosis apparatus of the present invention illustrating the deployment of three secondary energy delivery devices from a distal end of the insulation sleeve surrounding the primary energy delivery device.
  • FIG. 8 is a perspective view of the cell necrosis apparatus of the present invention illustrating the deployment of two secondary energy delivery devices from the primary energy delivery device, and the deployment of three secondary energy delivery devices from the distal end of the insulation sleeve surrounding the primary energy delivery device.
  • FIG. 9 is a block diagram illustrating the inclusion of a controller, electromagnetic energy source and other electronic components of the present invention.
  • FIG. 10 is a block diagram illustrating an analog amplifier, analog multiplexer and microprocessor used with the present invention.
  • the present invention provides a cell necrosis apparatus with a flexible introducer.
  • the apparatus is configured to be coupled to an energy source, a flexible introducer including a distal end, and a hollow lumen extending through the introducer and an energy delivery device with two or more energy delivery devices.
  • the energy delivery devices can be initially positioned in the introducer lumen as the introducer is introduced through tissue or positioned in the introducer after or during its advancement through tissue. At a selected tissue site the energy delivery devices are deployable from the introducer lumen in a lateral direction relative to the longitudinal axis.
  • Each of the deployed energy delivery devices has an electromagnetic energy delivery surface of sufficient size to, (i) create a volumetric cell necrosis between the deployed energy delivery devices, and (ii) create the volumetric cell necrosis without impeding out any of the deployed energy delivery devices when 5 to 200 watts of electromagnetic energy is delivered from the electromagnetic energy source to the cell necrosis apparatus.
  • At least one cable couples the cell necrosis apparatus to the electromagnetic energy source.
  • the term “impeding out” means that a tissue area has become sufficiently desiccated or carbonized that the desiccated or carbonized tissue area has a resultant high electrical resistance that impairs the process of creating a coagulating lesion.
  • cell necrosis apparatus 12 includes a flexible introducer 14 , and one or more energy delivery devices 16 , which are typically electrodes. Energy delivery devices 16 are initially positioned in an introducer lumen when introducer 14 is advanced through tissue. When introducer 14 reaches a selected tissue site, including but not limited to a solid lesion, energy delivery devices 16 are laterally deployed. Volumetric cell necrosis proceeds from the interior of the selected tissue mass in a direction towards a periphery of the selected tissue mass.
  • Each energy delivery device has a distal end 16 ′ which distends away from and can to surround a selected mass and may come back upon itself. Unless the distal ends 16 ′ have insulation, then their entire length of extension is an electromagnetic energy delivery surface which delivers electromagnetic energy to the selected tissue mass.
  • the length and size of each electromagnetic energy delivery surface can be variable. Lengths of energy delivery devices 16 can be adjustable. Introducer 14 can be moved up and down, rotated about its longitudinal axis, and moved back and forth, in order to define, along with sensors, the periphery or boundary of the selected tissue mass, including but not limited to a tumor. This provides a variety of different geometries, not always symmetrical, that can be ablated.
  • Volumetric cell necrosis is defined as the creation of cell necrosis with a periphery formed between adjacent distal ends 16 ′.
  • the volume of non-ablated tissue between adjacent distal ends 16 ′ is minimized.
  • a variety of different geometric cell necrosis zones are achieved including but not limited to spherical, semi-spherical, spheroid, triangular, semi-triangular, square, semi-square, rectangular, semi-rectangular, conical, semi-conical, quadrilateral, semi-quadrilateral, semi-quadrilateral, rhomboidal, semi-rhomboidal, trapezoidal, semi-trapezoidal, combinations of the preceding, geometries with non-planar sections or sides, free-form and the like.
  • introducer 14 can have a sharpened distal end 14 ′ to assist introduction through tissue.
  • Each energy delivery device 16 has a distal end 16 ′ that can be constructed to be less structurally rigid than introducer 14 .
  • Distal end 16 ′ is the section of energy delivery device 16 that is advanced from the lumen introducer 14 and into the selected tissue mass.
  • Introducer 14 is sufficiently flexible to pierce tissue, and move in any direction through tissue to a selected tissue site. Introducer 14 is sufficiently flexible enough to come back upon itself. In one embodiment, introducer 14 is more flexible than energy delivery devices 16 .
  • Energy delivery devices 16 can be made of a variety of conductive materials, both metallic and non-metallic.
  • One suitable material is type 304 stainless steel of hypodermic quality.
  • all or a portion of secondary energy delivery device 16 can be made of a shaped memory metal, such as NiTi, commercially available from Raychem Corporation, Menlo Park, Calif.
  • Each of the energy delivery devices 16 can have different lengths.
  • the lengths can be determined by the actual physical length of an energy delivery device 16 , the length of an energy delivery device electromagnetic energy delivery surface, and the length of an energy delivery device 16 that is not covered by an insulator. Suitable lengths include but are not limited to 17.5 cm, 25.0 cm. and 30.0 cm.
  • the actual length of an energy delivery device 16 depends on the location of the selected tissue mass to be ablated, its distance from the skin, its accessibility as well as whether or not the physician chooses a laparoscopic, percutaneous or other procedure.
  • An insulation sleeve 18 may be positioned around an exterior of introducer 14 and/or energy delivery devices 16 . All or some of insulation sleeves 18 may be adjustably positioned so that the length of an energy delivery device electromagnetic energy delivery surface can be varied. Each insulation sleeve 18 surrounding an introducer 14 can include one or more apertures. This permits the introduction of a energy delivery device 16 through introducer 14 and insulation sleeve 18 .
  • insulation sleeve 18 comprises a polyamide material.
  • a sensor 24 may be positioned on top of polyimide insulation sleeve 18 .
  • the polyamide insulation sleeve 18 is semi-rigid. Sensor 24 can lay down substantially along the entire length of polyamide insulation sleeve 18 .
  • Introducer 14 is made of a flexible material.
  • Energy delivery devices 16 have distal ends 16 ′ that are made of NiTi hypodermic tubing.
  • a handle is included with markings to show the length of lateral deployment of energy delivery devices 16 from introducer 14 . Fluid infusion is delivered through a Luer port at a side of the handle.
  • Type-T thermocouples are positioned at distal ends 16 ′.
  • Electromagnetic energy source 20 is configured to be coupled to cell necrosis apparatus 12 with one or more cables 22 .
  • Electromagnetic energy source 20 can be an RF source, microwave source, short wave source, laser source and the like.
  • Cell necrosis apparatus 12 can be comprised of energy delivery devices 16 that are RF electrodes, microwave antennas, as well as combinations thereof.
  • Electromagnetic energy source 20 may be a combination RF/microwave box.
  • a laser optical fiber, coupled to a laser source 20 can be introduced through one or both of introducer 14 or a energy delivery device 16 .
  • Introducer 14 and/or a secondary electrode 16 can be an arm for the purposes of introducing the optical fiber.
  • Energy delivery devices 16 are electromagnetically coupled to electromagnetic energy source 20 .
  • the coupling can be direct from electromagnetic energy source 20 to each energy delivery device 16 , or indirect by using a collet, sleeve and the like which couples one or more energy delivery devices 16 to electromagnetic energy source 20 .
  • Electromagnetic energy can be delivered from one energy delivery device 16 to another.
  • One or more sensors 24 may be positioned on at least a portion of interior or exterior surfaces of introducer 14 , energy delivery device 16 or insulation sleeve 18 .
  • sensors 24 are positioned at introducer distal end 14 ′, energy delivery device distal end 16 ′ and insulation sleeve distal end 18 ′.
  • Sensors 24 permit accurate measurement of temperature at a tissue site in order to determine, (i) the extent of cell necrosis, (ii) the amount of cell necrosis, (iii) whether or not further cell necrosis is needed and (iv) the boundary or periphery of the ablated mass. Further, sensors 24 prevent non-targeted tissue from being destroyed or ablated. Atty Docket No.: 1372 - 4797
  • Sensors 24 are of conventional design, including but not limited to thermistors, thermocouples, resistive wires, and the like. Suitable thermal sensors 24 include a T type thermocouple with copper constantene, J type, E type, K type, fiber optics, resistive wires, thermocouple IR detectors, and the like. It will be appreciated that sensors 24 need not be thermal sensors.
  • Sensors 24 measure temperature and/or impedance to permit monitoring and a desired level of cell necrosis to be achieved without destroying too much tissue. This reduces damage to tissue surrounding the targeted mass to be ablated. By monitoring the temperature at various points within the interior of the selected tissue mass, a determination of the selected tissue mass periphery can be made, as well as a determination of when cell necrosis is complete. If at any time sensor 24 determines that a desired cell necrosis temperature is exceeded, then an appropriate feedback signal is received at electromagnetic energy source 20 which then regulates the amount of electromagnetic energy delivered to energy delivery devices 16 .
  • the geometry of the ablated mass is selectable and controllable. Any number of different cell necrosis geometries can be achieved. Creation of different cell necrosis geometries is dependent on the length of electromagnetic energy cell necrosis delivery surfaces, the number of energy delivery devices, the size of the electromagnetic delivery surfaces, the amount of power delivered to the energy delivery devices, and the duration of time for power delivery to the energy delivery devices.
  • Energy delivery device distal ends 16 ′ can be deployed from aperture 26 and distend away from introducer 14 in any number of different configurations, including but not limited to a “U” shape.
  • Aperture 26 is at distal end 14 ′ or formed in a side of an exterior of introducer 14 .
  • a method for creating a volumetric cell necrosis in a selected tissue mass provides cell necrosis apparatus 12 including introducer 14 with an introducer lumen, a plurality of energy delivery devices 16 deployable from the lumen, and an electromagnetic energy source 20 coupled to the plurality of energy delivery devices.
  • Introducer 14 is inserted into the selected tissue mass with the plurality of energy delivery devices positioned in the introducer 14 lumen.
  • the plurality of energy delivery devices 16 are advanced from the introducer lumen to distend away from introducer 14 to surround a selected mass before or after introducer 14 has pierced the selected cell necrosis site.
  • 5 to 200 watts, preferably 5 to 100, and still more preferably 5 to 50 watts of electromagnetic energy is delivered from electromagnetic energy source 20 to the plurality of energy delivery devices 16 without impeding out an energy delivery device of the plurality of energy delivery devices.
  • the volumetric cell necrosis is created between the plurality of energy delivery devices 16 .
  • energy delivery device 16 can be deflected a few degrees from the longitudinal axis of introducer 14 , or energy delivery devices 16 can be deflected in any number of geometric configurations, including but not limited to a “J” hook. Further, energy delivery devices 16 are capable of being introduced from introducer 14 a few millimeters from introducer 14 , or a much larger distance. In one embodiment, a distal portion of introducer 14 can also be an electromagnetic energy delivery surface.
  • introducer 14 is introduced into a selected tissue mass 28 .
  • Three or more energy delivery devices 16 are positioned within an introducer lumen as introducer 14 is introduced into and through the selected tissue mass.
  • 3, 4, 5, or 6 energy delivery devices 16 are introduced laterally through introducer 14 .
  • energy delivery device distal end 16 ′ is advanced out of aperture 26 into selected tissue mass 28 .
  • Insulation sleeves 18 are adjusted for energy delivery devices 16 .
  • RF, microwave, short wave and the like energy is delivery to energy delivery device 16 in a monopolar mode (RF), or alternatively, cell necrosis apparatus 12 can be operated in a bipolar mode (RF).
  • Cell necrosis apparatus 12 can be switched between monopolar and bipolar operation and may have multiplexing capability between different energy delivery devices 16 .
  • Energy delivery device distal ends 16 ′ is retracted back into introducer 14 , and introducer is then rotated.
  • Energy delivery device distal end 16 ′ is then introduced into selected tissue mass 28 .
  • Energy delivery devices 16 may be introduced a short distance into selected tissue mass 28 to ablate a small area, e.g., 3 cm or less. It can then be advanced further into any number of times to create more cell necrosis zones.
  • introducer 14 can be, (i) rotated again, (ii) moved along a longitudinal axis of selected tissue mass 28 to begin another series of cell necrosis zones with energy delivery device distal ends 16 ′ being introduced and retracted in and out of introducer 14 , or (iii) removed from selected tissue mass 28 .
  • a number of parameters permit cell necrosis of selected tissue masses 28 of different sign and shapes including a series of cell necrosis zones having energy delivery devices 16 with variable length electromagnetic energy delivery surfaces and the use of one or more sensors 24 .
  • two energy delivery devices 16 are each deployed out of distal end 14 ′ and introduced into selected tissue mass 28 .
  • Energy delivery devices 16 form a plane and the area of cell necrosis extends between the electromagnetic energy delivery surfaces of energy delivery devices 16 .
  • Introducer 14 can be introduced in an adjacent relationship to selected tissue mass 28 . This particular deployment is useful for small selected tissue masses 28 , or where piercing selected tissue mass 28 is not desirable.
  • Introducer 14 can be rotated, with energy delivery devices 16 retracted in the lumen of introducer 14 , and another cell necrosis volume defined between the energy delivery devices 16 is created.
  • introducer 14 can be withdrawn from its initial position adjacent to selected tissue mass 28 , repositioned to another position adjacent to selected tissue mass 28 , and energy delivery devices 16 deployed to begin another cell necrosis cycle. Any variety of different positions may be utilized to create a desired cell necrosis geometry for selected tissue mass of different geometries and sizes.
  • FIG. 4 three energy delivery devices 16 are introduced into selected tissue mass 28 .
  • the effect is the creation of a substantially complete cell necrosis volume formed between energy delivery devices 16 with a minimal central core that is not ablated.
  • Cell necrosis apparatus 12 can be operated in the bipolar mode between the two energy delivery devices 16 , or between a energy delivery device 16 and introducer 14 . Alternatively, cell necrosis apparatus 12 can be operated in a monopolar mode.
  • Energy delivery devices 16 can serve the additional function of anchoring cell necrosis apparatus 12 in a selected mass, as illustrated in FIGS. 6 ( a ) and 6 ( b ).
  • FIG. 6( a ) one or both energy delivery devices 16 are used to anchor and position introducer 14 . Further, one or both energy delivery devices 16 are also used to ablate tissue.
  • FIG. 6( b ) three energy delivery devices are deployed and anchor introducer 14 .
  • FIG. 6( c ) illustrates the infusion capability of cell necrosis apparatus 12 .
  • Three energy delivery devices 16 are positioned in a central lumen 14 ′′ of introducer 14 .
  • One or more of the energy delivery devices 16 can also include a central lumen coupled to an infusion source.
  • Central lumen 14 ′′ is coupled to an infusion source and delivers a variety of infusion mediums to selected places both within and outside of the targeted cell necrosis mass.
  • Suitable infusion mediums include but are not limited to, therapeutic agents, conductivity enhancement mediums, contrast agents or dyes, and the like.
  • An example of a therapeutic agent is a chemotherapeutic agent.
  • insulation sleeve 18 can include one or more lumens for receiving energy delivery devices 16 which are deployed out of an insulation sleeve distal end 18 ′.
  • FIG. 8 illustrates two energy delivery devices 16 being introduced out of insulation sleeve distal end 18 ′, and two energy delivery devices 16 introduced through apertures 26 formed in introducer 14 . As illustrated, energy delivery devices 16 introduced through apertures 26 provide an anchoring function.
  • FIG. 8 illustrates that energy delivery devices 16 can have a variety of different geometric configurations in cell necrosis apparatus 12 .
  • a feedback control system 29 is connected to electromagnetic energy source 20 , sensors 24 and energy delivery devices 16 .
  • Feedback control system 29 receives temperature or impedance data from sensors 24 and the amount of electromagnetic energy received by energy delivery devices 16 is modified from an initial setting of cell necrosis energy output, cell necrosis time, temperature, and current density (the “Four Parameters”).
  • Feedback control system 29 can automatically change any of the Four Parameters.
  • Feedback control system 29 can detect impedance or temperature and change any of the four parameters.
  • Feedback control system 29 can include a multiplexer to multiplex different energy delivery devices, a temperature detection circuit that provides a control signal representative of temperature or impedance detected at one or more sensors 24 .
  • a microprocessor can be connected to the temperature control circuit.
  • a control signal is generated by controller 38 that is proportional to the difference between an actual measured value, and a desired value.
  • the control signal is used by power circuits 40 to adjust the power output in an appropriate amount in order to maintain the desired power delivered at energy delivery devices 16 .
  • temperatures detected at sensors 24 provide feedback for determining the extent of cell necrosis, and when a completed cell necrosis has reached the physical location of sensors 24 .
  • the actual temperatures are measured at temperature measurement device 42 and the temperatures are displayed at user interface and display 36 .
  • a control signal is generated by controller 38 that is proportional to the difference between an actual measured temperature, and a desired temperature.
  • the control signal is used by power circuits 40 to adjust the power output in an appropriate amount in order to maintain the desired temperature delivered at the respective sensor 24 .
  • a multiplexer can be included to measure current, voltage and temperature, at the numerous sensors 24 , and energy is delivered to energy delivery devices 16 .
  • Controller 38 can be a digital or analog controller, or a computer with software.
  • controller 38 When controller 38 is a computer it can include a CPU coupled through a system bus. On this system can be a keyboard, a disk drive, or other non-volatile memory systems, a display, and other peripherals, as are known in the art. Also coupled to the bus are a program memory and a data memory.
  • User interface and display 36 includes operator controls and a display.
  • Controller 38 can be coupled to imaging systems, including but not limited to ultrasound, CT scanners, X-ray, MRI, mammographic X-ray and the like. Further, direct visualization and tactile imaging can be utilized.
  • the output of current sensor 30 and voltage sensor 32 is used by controller 38 to maintain a selected power level at energy delivery devices 16 .
  • the amount of RF energy delivered controls the amount of power.
  • a profile of power delivered can be incorporated in controller 38 , and a preset amount of energy to be delivered can also be profiled.
  • Circuitry, software and feedback to controller 38 result in process control, and the maintenance of the selected power, and are used to change, (i) the selected power, including RF, microwave, laser and the like, (ii) the duty cycle (on-off and wattage), (iii) bipolar or monopolar energy delivery and (iv) infusion medium delivery, including flow rate and pressure.
  • process variables are controlled and varied, while maintaining the desired delivery of power independent of changes in voltage or current, based on temperatures monitored at sensors 24 .
  • Analog amplifier 44 can be a conventional differential amplifier circuit for use with sensors 24 .
  • the output of analog amplifier 44 is sequentially connected by an analog multiplexer 46 to the input of A/D converter 48 .
  • the output of analog amplifier 44 is a voltage which represents the respective sensed temperatures.
  • Digitized amplifier output voltages are supplied by A/D converter 48 to a microprocessor 50 .
  • Microprocessor 50 may be Model No. 68HCII available from Motorola. However, it will be appreciated that any suitable microprocessor or general purpose digital or analog computer can be used to calculate impedance or temperature.
  • Microprocessor 50 sequentially receives and stores digital representations of impedance and temperature. Each digital value received by microprocessor 50 corresponds to different temperatures and impedances.
  • Calculated power and impedance values can be indicated on user interface and display 36 .
  • calculated impedance and power values can be compared by microprocessor 50 with power and impedance limits. When the values exceed predetermined power or impedance values, a warning can be given on user interface and display 36 , and additionally, the delivery of RF energy can be reduced, modified or interrupted.
  • a control signal from microprocessor 50 can modify the power level supplied by electromagnetic energy source 20 .

Abstract

A cell necrosis apparatus has a flexible introducer including a lumen and a distal end sufficiently sharp to penetrate tissue. An energy delivery device is positionable in the introducer as the introducer is advanced through tissue. The energy delivery device includes a first RF electrode with a tissue piercing distal portion and a second RF electrode with a tissue piercing distal portion. The first and second RF electrodes are deployable with curvature from the introducer at a selected tissue site in a lateral direction away from the periphery of the introducer.

Description

    REFERENCE TO RELATED APPLICATIONS
  • This application is a continuation of U.S. patent application Ser. No. 09/028,436, which is a continuation-in-part of U.S. Pat. application Ser. No. 09/020,182, filed Feb. 6, 1998, which is a continuation-in-part of U.S. application No. 08/963,239, filed Nov. 3, 1997, which is a continuation-in-part of U.S. Pat. application No. 08/605,323, filed Feb. 14, 1996, which is a continuation-in-part of U.S. Pat. application No. 08/515,379, filed Aug. 15, 1995, all incorporated herein by reference.[0001]
    • BACKGROUND OF THE INVENTION
  • 1. Field of the Invention [0002]
  • This invention relates generally to a cell necrosis apparatus, and more particularly to a cell necrosis apparatus with a flexible introducer. [0003]
  • 2. Description of the Related Art [0004]
  • Current open procedures for treatment of tumors are extremely disruptive and cause a great deal of damage to healthy tissue. During the surgical procedure, the physician must exercise care in not cutting the tumor in a manor that creates seeding of the tumor, resulting in metastasis. In recent years, development of products has been directed with an emphasis on minimizing the traumatic nature of traditional surgical procedures. [0005]
  • There has been a relatively significant amount of activity in the area of hyperthermia as a tool for treatment of tumors. It is known that elevating the temperature of tumors is helpful in the treatment and management of cancerous tissues. The mechanisms of selective cancer cell eradication by hyperthermia are not completely understood. However, four cellular effects of hyperthermia on cancerous tissue have been proposed, (i) changes in cell or nuclear membrane permeability or fluidity, (ii) cytoplasmic lysomal disintegration, causing release of digestive enzymes, (iii) protein thermal damage affecting cell respiration and the synthesis of DNA or RNA and (iv) potential excitation of immunologic systems. Treatment methods for applying heat to tumors include the use of direct contact radio-frequency (RF) applicators, microwave radiation, inductively coupled RF fields, ultrasound, and a variety of simple thermal conduction techniques. [0006]
  • Among the problems associated with all of these procedures is the requirement that highly localized heat be produced at depths of several centimeters beneath the surface of the skin. [0007]
  • Attempts to use interstitial local hyperthermia have not proven to be very successful. Results have often produced nonuniform temperatures throughout the tumor. It is believed that tumor mass reduction by hyperthermia is related to thermal dose. Thermal dose is the minimum effective temperature applied throughout the tumor mass for a defined period of time. Because blood flow is the major mechanism of heat loss for tumors being heated, and blood flow varies throughout the tumor, more even heating of tumor tissue is needed to ensure effective treatment. [0008]
  • The same is true for ablation of the tumor itself through the use of RF energy. Different methods have been utilized for the RF ablation of masses such as tumors. Instead of heating the tumor it is ablated through the application of energy. This process has been difficult to achieve due to a variety of factors including, (i) positioning of the RF ablation electrodes to effectively ablate all of the mass, (ii) introduction of the RF ablation electrodes to the tumor site and (iii) controlled delivery and monitoring of RF energy to achieve successful ablation without damage to non-tumor tissue. [0009]
  • Thus, non-invasive procedures for providing heat to internal tissue have had difficulties in achieving substantial specific and selective treatment. [0010]
  • Examples illustrating the use of electromagnetic energy to ablate tissue are disclosed in: U.S. Pat. No. 4,562,200; U.S. Pat. No. 4,411,266; U.S. Pat. No. 4,838,265; U.S. Pat. No. 5,403,311; U.S. Pat. No. 4,011,872; U.S. Pat. No. 5,385, 544; and U.S. Pat. No. 5,385,544. [0011]
  • There is a need for a cell necrosis apparatus with a flexible introducer. There is another need for a cell necrosis apparatus with an introducer that is flexible enough to come back upon itself. There is yet another need for a cell necrosis apparatus with an introducer that is advanceable through or around a selected target cell necrosis mass, and be flexibly positioned at any desired site in tissue. [0012]
    • SUMMARY OF THE INVENTION
  • Accordingly, an object of the invention is to provide a cell necrosis apparatus that provides tissue reduction at selected anatomical sites. [0013]
  • Another object of the invention is to provide a treatment apparatus to create cell necrosis. [0014]
  • Another object of the invention is to provide a cell necrosis apparatus with a flexible introducer. [0015]
  • Still another object of the invention is to provide a cell necrosis apparatus with an introducer that is flexible enough to come back upon itself. [0016]
  • A further object of the invention is to provide a cell necrosis apparatus with an introducer that is configured to be advanceable through or around a selected target cell necrosis mass, and be flexibly positioned at any desired site in tissue. [0017]
  • These and other objects of the invention are achieved in a cell necrosis apparatus with a flexible introducer including a lumen and a distal end sufficiently sharp to penetrate tissue. [0018]
  • An energy delivery device is positionable in the introducer as the introducer is advanced through tissue. The energy delivery device includes a first RF electrode with a tissue piercing distal portion and a second RF electrode with a tissue piercing distal portion. The first and second RF electrodes are deployable with curvature from the introducer at a selected tissue site in a lateral direction away from the periphery of the introducer. [0019]
  • In another embodiment, the cell necrosis apparatus has a flexible introducer. The energy delivery device includes a first RF electrode with a tissue piercing distal portion, a second RF electrode with a tissue piercing distal portion and a third RF electrode with a tissue piercing distal portion. The first, second and third RF electrodes are positionable in the introducer as the introducer is advanced through tissue and deployable with curvature in a radially divergent configuration when extended beyond the introducer.[0020]
    • BRIEF DESCRIPTION OF THE FIGURES
  • FIG. 1 is a perspective view of the cell necrosis apparatus of the present invention illustrating a flexible introducer and three laterally deployed energy delivery devices. [0021]
  • FIG. 2 is a perspective view of a conic geometric ablation achieved with the apparatus of FIG. 1. [0022]
  • FIG. 3 is a perspective view of the cell necrosis apparatus of the present invention with two energy delivery devices. [0023]
  • FIG. 4 is a perspective view illustrating three energy delivery devices creating a complete cell necrosis volume. [0024]
  • FIG. 5 is a perspective view illustrating the positioning of the cell necrosis apparatus in the center of a selected tissue mass, and the creation of a cylindrical ablation. [0025]
  • FIG. 6([0026] a) is a perspective view of the cell necrosis of the present invention illustrating two energy delivery devices which provide a retaining and gripping function.
  • FIG. 6([0027] b) is a perspective view of the cell necrosis apparatus of the present invention illustrating three secondary energy delivery devices which provide a retaining and gripping function.
  • FIG. 6([0028] c) is a cross-sectional view of the apparatus of FIG. 6(b) taken along the lines 6(c)-6(c).
  • FIG. 7 is a perspective view of the cell necrosis apparatus of the present invention illustrating the deployment of three secondary energy delivery devices from a distal end of the insulation sleeve surrounding the primary energy delivery device. [0029]
  • FIG. 8 is a perspective view of the cell necrosis apparatus of the present invention illustrating the deployment of two secondary energy delivery devices from the primary energy delivery device, and the deployment of three secondary energy delivery devices from the distal end of the insulation sleeve surrounding the primary energy delivery device. [0030]
  • FIG. 9 is a block diagram illustrating the inclusion of a controller, electromagnetic energy source and other electronic components of the present invention. [0031]
  • FIG. 10 is a block diagram illustrating an analog amplifier, analog multiplexer and microprocessor used with the present invention.[0032]
    • DETAILED DESCRIPTION
  • The present invention provides a cell necrosis apparatus with a flexible introducer. The apparatus is configured to be coupled to an energy source, a flexible introducer including a distal end, and a hollow lumen extending through the introducer and an energy delivery device with two or more energy delivery devices. The energy delivery devices can be initially positioned in the introducer lumen as the introducer is introduced through tissue or positioned in the introducer after or during its advancement through tissue. At a selected tissue site the energy delivery devices are deployable from the introducer lumen in a lateral direction relative to the longitudinal axis. Each of the deployed energy delivery devices has an electromagnetic energy delivery surface of sufficient size to, (i) create a volumetric cell necrosis between the deployed energy delivery devices, and (ii) create the volumetric cell necrosis without impeding out any of the deployed energy delivery devices when 5 to 200 watts of electromagnetic energy is delivered from the electromagnetic energy source to the cell necrosis apparatus. At least one cable couples the cell necrosis apparatus to the electromagnetic energy source. For purposes of this specification the term “impeding out” means that a tissue area has become sufficiently desiccated or carbonized that the desiccated or carbonized tissue area has a resultant high electrical resistance that impairs the process of creating a coagulating lesion. [0033]
  • As shown in FIG. 1, [0034] cell necrosis apparatus 12 includes a flexible introducer 14, and one or more energy delivery devices 16, which are typically electrodes. Energy delivery devices 16 are initially positioned in an introducer lumen when introducer 14 is advanced through tissue. When introducer 14 reaches a selected tissue site, including but not limited to a solid lesion, energy delivery devices 16 are laterally deployed. Volumetric cell necrosis proceeds from the interior of the selected tissue mass in a direction towards a periphery of the selected tissue mass.
  • Each energy delivery device has a [0035] distal end 16′ which distends away from and can to surround a selected mass and may come back upon itself. Unless the distal ends 16′ have insulation, then their entire length of extension is an electromagnetic energy delivery surface which delivers electromagnetic energy to the selected tissue mass. The length and size of each electromagnetic energy delivery surface can be variable. Lengths of energy delivery devices 16 can be adjustable. Introducer 14 can be moved up and down, rotated about its longitudinal axis, and moved back and forth, in order to define, along with sensors, the periphery or boundary of the selected tissue mass, including but not limited to a tumor. This provides a variety of different geometries, not always symmetrical, that can be ablated. Volumetric cell necrosis is defined as the creation of cell necrosis with a periphery formed between adjacent distal ends 16′. The volume of non-ablated tissue between adjacent distal ends 16′ is minimized. A variety of different geometric cell necrosis zones are achieved including but not limited to spherical, semi-spherical, spheroid, triangular, semi-triangular, square, semi-square, rectangular, semi-rectangular, conical, semi-conical, quadrilateral, semi-quadrilateral, semi-quadrilateral, rhomboidal, semi-rhomboidal, trapezoidal, semi-trapezoidal, combinations of the preceding, geometries with non-planar sections or sides, free-form and the like.
  • In one embodiment, [0036] introducer 14 can have a sharpened distal end 14′ to assist introduction through tissue. Each energy delivery device 16 has a distal end 16′ that can be constructed to be less structurally rigid than introducer 14. Distal end 16′ is the section of energy delivery device 16 that is advanced from the lumen introducer 14 and into the selected tissue mass.
  • [0037] Introducer 14 is sufficiently flexible to pierce tissue, and move in any direction through tissue to a selected tissue site. Introducer 14 is sufficiently flexible enough to come back upon itself. In one embodiment, introducer 14 is more flexible than energy delivery devices 16.
  • [0038] Energy delivery devices 16 can be made of a variety of conductive materials, both metallic and non-metallic. One suitable material is type 304 stainless steel of hypodermic quality. In some applications, all or a portion of secondary energy delivery device 16 can be made of a shaped memory metal, such as NiTi, commercially available from Raychem Corporation, Menlo Park, Calif.
  • Each of the [0039] energy delivery devices 16 can have different lengths. The lengths can be determined by the actual physical length of an energy delivery device 16, the length of an energy delivery device electromagnetic energy delivery surface, and the length of an energy delivery device 16 that is not covered by an insulator. Suitable lengths include but are not limited to 17.5 cm, 25.0 cm. and 30.0 cm. The actual length of an energy delivery device 16 depends on the location of the selected tissue mass to be ablated, its distance from the skin, its accessibility as well as whether or not the physician chooses a laparoscopic, percutaneous or other procedure.
  • An [0040] insulation sleeve 18 may be positioned around an exterior of introducer 14 and/or energy delivery devices 16. All or some of insulation sleeves 18 may be adjustably positioned so that the length of an energy delivery device electromagnetic energy delivery surface can be varied. Each insulation sleeve 18 surrounding an introducer 14 can include one or more apertures. This permits the introduction of a energy delivery device 16 through introducer 14 and insulation sleeve 18.
  • In one embodiment, [0041] insulation sleeve 18 comprises a polyamide material. A sensor 24 may be positioned on top of polyimide insulation sleeve 18. The polyamide insulation sleeve 18 is semi-rigid. Sensor 24 can lay down substantially along the entire length of polyamide insulation sleeve 18. Introducer 14 is made of a flexible material. Energy delivery devices 16 have distal ends 16′ that are made of NiTi hypodermic tubing. A handle is included with markings to show the length of lateral deployment of energy delivery devices 16 from introducer 14. Fluid infusion is delivered through a Luer port at a side of the handle. Type-T thermocouples are positioned at distal ends 16′.
  • An [0042] electromagnetic energy source 20 is configured to be coupled to cell necrosis apparatus 12 with one or more cables 22. Electromagnetic energy source 20 can be an RF source, microwave source, short wave source, laser source and the like. Cell necrosis apparatus 12 can be comprised of energy delivery devices 16 that are RF electrodes, microwave antennas, as well as combinations thereof. Electromagnetic energy source 20 may be a combination RF/microwave box. Further a laser optical fiber, coupled to a laser source 20 can be introduced through one or both of introducer 14 or a energy delivery device 16. Introducer 14 and/or a secondary electrode 16 can be an arm for the purposes of introducing the optical fiber.
  • [0043] Energy delivery devices 16 are electromagnetically coupled to electromagnetic energy source 20. The coupling can be direct from electromagnetic energy source 20 to each energy delivery device 16, or indirect by using a collet, sleeve and the like which couples one or more energy delivery devices 16 to electromagnetic energy source 20. Electromagnetic energy can be delivered from one energy delivery device 16 to another.
  • One or [0044] more sensors 24 may be positioned on at least a portion of interior or exterior surfaces of introducer 14, energy delivery device 16 or insulation sleeve 18. Preferably sensors 24 are positioned at introducer distal end 14′, energy delivery device distal end 16′ and insulation sleeve distal end 18′. Sensors 24 permit accurate measurement of temperature at a tissue site in order to determine, (i) the extent of cell necrosis, (ii) the amount of cell necrosis, (iii) whether or not further cell necrosis is needed and (iv) the boundary or periphery of the ablated mass. Further, sensors 24 prevent non-targeted tissue from being destroyed or ablated. Atty Docket No.: 1372-4797
  • [0045] Sensors 24 are of conventional design, including but not limited to thermistors, thermocouples, resistive wires, and the like. Suitable thermal sensors 24 include a T type thermocouple with copper constantene, J type, E type, K type, fiber optics, resistive wires, thermocouple IR detectors, and the like. It will be appreciated that sensors 24 need not be thermal sensors.
  • [0046] Sensors 24 measure temperature and/or impedance to permit monitoring and a desired level of cell necrosis to be achieved without destroying too much tissue. This reduces damage to tissue surrounding the targeted mass to be ablated. By monitoring the temperature at various points within the interior of the selected tissue mass, a determination of the selected tissue mass periphery can be made, as well as a determination of when cell necrosis is complete. If at any time sensor 24 determines that a desired cell necrosis temperature is exceeded, then an appropriate feedback signal is received at electromagnetic energy source 20 which then regulates the amount of electromagnetic energy delivered to energy delivery devices 16.
  • Thus the geometry of the ablated mass is selectable and controllable. Any number of different cell necrosis geometries can be achieved. Creation of different cell necrosis geometries is dependent on the length of electromagnetic energy cell necrosis delivery surfaces, the number of energy delivery devices, the size of the electromagnetic delivery surfaces, the amount of power delivered to the energy delivery devices, and the duration of time for power delivery to the energy delivery devices. [0047]
  • Energy delivery device distal ends [0048] 16′ can be deployed from aperture 26 and distend away from introducer 14 in any number of different configurations, including but not limited to a “U” shape. Aperture 26 is at distal end 14′ or formed in a side of an exterior of introducer 14.
  • In one embodiment, a method for creating a volumetric cell necrosis in a selected tissue mass provides [0049] cell necrosis apparatus 12 including introducer 14 with an introducer lumen, a plurality of energy delivery devices 16 deployable from the lumen, and an electromagnetic energy source 20 coupled to the plurality of energy delivery devices. Introducer 14 is inserted into the selected tissue mass with the plurality of energy delivery devices positioned in the introducer 14 lumen. The plurality of energy delivery devices 16 are advanced from the introducer lumen to distend away from introducer 14 to surround a selected mass before or after introducer 14 has pierced the selected cell necrosis site. 5 to 200 watts, preferably 5 to 100, and still more preferably 5 to 50 watts of electromagnetic energy is delivered from electromagnetic energy source 20 to the plurality of energy delivery devices 16 without impeding out an energy delivery device of the plurality of energy delivery devices. The volumetric cell necrosis is created between the plurality of energy delivery devices 16.
  • There is wide variation in the amount of deflection of [0050] energy delivery device 16. For example, energy delivery device 16 can be deflected a few degrees from the longitudinal axis of introducer 14, or energy delivery devices 16 can be deflected in any number of geometric configurations, including but not limited to a “J” hook. Further, energy delivery devices 16 are capable of being introduced from introducer 14 a few millimeters from introducer 14, or a much larger distance. In one embodiment, a distal portion of introducer 14 can also be an electromagnetic energy delivery surface.
  • As illustrated in FIG. 2, [0051] introducer 14 is introduced into a selected tissue mass 28. Three or more energy delivery devices 16 are positioned within an introducer lumen as introducer 14 is introduced into and through the selected tissue mass. In various embodiments, 3, 4, 5, or 6 energy delivery devices 16 are introduced laterally through introducer 14. Subsequently, energy delivery device distal end 16′ is advanced out of aperture 26 into selected tissue mass 28. Insulation sleeves 18 are adjusted for energy delivery devices 16. RF, microwave, short wave and the like energy is delivery to energy delivery device 16 in a monopolar mode (RF), or alternatively, cell necrosis apparatus 12 can be operated in a bipolar mode (RF). Cell necrosis apparatus 12 can be switched between monopolar and bipolar operation and may have multiplexing capability between different energy delivery devices 16. Energy delivery device distal ends 16′ is retracted back into introducer 14, and introducer is then rotated. Energy delivery device distal end 16′ is then introduced into selected tissue mass 28. Energy delivery devices 16 may be introduced a short distance into selected tissue mass 28 to ablate a small area, e.g., 3 cm or less. It can then be advanced further into any number of times to create more cell necrosis zones. Again, energy delivery device distal end 16′ is retracted back into introducer 14, and introducer 14 can be, (i) rotated again, (ii) moved along a longitudinal axis of selected tissue mass 28 to begin another series of cell necrosis zones with energy delivery device distal ends 16′ being introduced and retracted in and out of introducer 14, or (iii) removed from selected tissue mass 28. A number of parameters permit cell necrosis of selected tissue masses 28 of different sign and shapes including a series of cell necrosis zones having energy delivery devices 16 with variable length electromagnetic energy delivery surfaces and the use of one or more sensors 24.
  • In FIG. 3, two [0052] energy delivery devices 16 are each deployed out of distal end 14′ and introduced into selected tissue mass 28. Energy delivery devices 16 form a plane and the area of cell necrosis extends between the electromagnetic energy delivery surfaces of energy delivery devices 16. Introducer 14 can be introduced in an adjacent relationship to selected tissue mass 28. This particular deployment is useful for small selected tissue masses 28, or where piercing selected tissue mass 28 is not desirable. Introducer 14 can be rotated, with energy delivery devices 16 retracted in the lumen of introducer 14, and another cell necrosis volume defined between the energy delivery devices 16 is created. Further, introducer 14 can be withdrawn from its initial position adjacent to selected tissue mass 28, repositioned to another position adjacent to selected tissue mass 28, and energy delivery devices 16 deployed to begin another cell necrosis cycle. Any variety of different positions may be utilized to create a desired cell necrosis geometry for selected tissue mass of different geometries and sizes.
  • In FIG. 4, three [0053] energy delivery devices 16 are introduced into selected tissue mass 28. The effect is the creation of a substantially complete cell necrosis volume formed between energy delivery devices 16 with a minimal central core that is not ablated.
  • Referring now to FIG. 5, a center of selected [0054] tissue mass 28 is pierced by introducer 14, energy delivery devices 16 are laterally deployed and retracted, introducer 14 is rotated, energy delivery devices 16 are deployed and retracted, and so on until a cylindrical cell necrosis volume is achieved. Cell necrosis apparatus 12 can be operated in the bipolar mode between the two energy delivery devices 16, or between a energy delivery device 16 and introducer 14. Alternatively, cell necrosis apparatus 12 can be operated in a monopolar mode.
  • [0055] Energy delivery devices 16 can serve the additional function of anchoring cell necrosis apparatus 12 in a selected mass, as illustrated in FIGS. 6(a) and 6(b). In FIG. 6(a) one or both energy delivery devices 16 are used to anchor and position introducer 14. Further, one or both energy delivery devices 16 are also used to ablate tissue. In FIG. 6(b), three energy delivery devices are deployed and anchor introducer 14.
  • FIG. 6([0056] c) illustrates the infusion capability of cell necrosis apparatus 12. Three energy delivery devices 16 are positioned in a central lumen 14″ of introducer 14. One or more of the energy delivery devices 16 can also include a central lumen coupled to an infusion source. Central lumen 14″ is coupled to an infusion source and delivers a variety of infusion mediums to selected places both within and outside of the targeted cell necrosis mass. Suitable infusion mediums include but are not limited to, therapeutic agents, conductivity enhancement mediums, contrast agents or dyes, and the like. An example of a therapeutic agent is a chemotherapeutic agent.
  • As shown in FIG. 7, [0057] insulation sleeve 18 can include one or more lumens for receiving energy delivery devices 16 which are deployed out of an insulation sleeve distal end 18′. FIG. 8 illustrates two energy delivery devices 16 being introduced out of insulation sleeve distal end 18′, and two energy delivery devices 16 introduced through apertures 26 formed in introducer 14. As illustrated, energy delivery devices 16 introduced through apertures 26 provide an anchoring function. FIG. 8 illustrates that energy delivery devices 16 can have a variety of different geometric configurations in cell necrosis apparatus 12.
  • A [0058] feedback control system 29 is connected to electromagnetic energy source 20, sensors 24 and energy delivery devices 16. Feedback control system 29 receives temperature or impedance data from sensors 24 and the amount of electromagnetic energy received by energy delivery devices 16 is modified from an initial setting of cell necrosis energy output, cell necrosis time, temperature, and current density (the “Four Parameters”). Feedback control system 29 can automatically change any of the Four Parameters. Feedback control system 29 can detect impedance or temperature and change any of the four parameters. Feedback control system 29 can include a multiplexer to multiplex different energy delivery devices, a temperature detection circuit that provides a control signal representative of temperature or impedance detected at one or more sensors 24. A microprocessor can be connected to the temperature control circuit.
  • The following discussion pertains particularly to the use of an RF energy source and RF electrodes but applies to other energy delivery devices and energy sources including but not limited to microwave, ultrasound, resistive heating, coherent and incoherent light, and the like. [0059]
  • Referring now to FIG. 9, all or portions of [0060] feedback control system 29 are illustrated. Current delivered through energy delivery devices 16 is measured by current sensor 30. Voltage is measured by voltage sensor 32. Impedance and power are then calculated at power and impedance calculation device 34. These values can then be displayed at user interface and display 36. Signals representative of power and impedance values are received by controller 38.
  • A control signal is generated by [0061] controller 38 that is proportional to the difference between an actual measured value, and a desired value. The control signal is used by power circuits 40 to adjust the power output in an appropriate amount in order to maintain the desired power delivered at energy delivery devices 16.
  • In a similar manner, temperatures detected at [0062] sensors 24 provide feedback for determining the extent of cell necrosis, and when a completed cell necrosis has reached the physical location of sensors 24. The actual temperatures are measured at temperature measurement device 42 and the temperatures are displayed at user interface and display 36. A control signal is generated by controller 38 that is proportional to the difference between an actual measured temperature, and a desired temperature. The control signal is used by power circuits 40 to adjust the power output in an appropriate amount in order to maintain the desired temperature delivered at the respective sensor 24. A multiplexer can be included to measure current, voltage and temperature, at the numerous sensors 24, and energy is delivered to energy delivery devices 16.
  • [0063] Controller 38 can be a digital or analog controller, or a computer with software. When controller 38 is a computer it can include a CPU coupled through a system bus. On this system can be a keyboard, a disk drive, or other non-volatile memory systems, a display, and other peripherals, as are known in the art. Also coupled to the bus are a program memory and a data memory.
  • User interface and [0064] display 36 includes operator controls and a display. Controller 38 can be coupled to imaging systems, including but not limited to ultrasound, CT scanners, X-ray, MRI, mammographic X-ray and the like. Further, direct visualization and tactile imaging can be utilized.
  • The output of [0065] current sensor 30 and voltage sensor 32 is used by controller 38 to maintain a selected power level at energy delivery devices 16. The amount of RF energy delivered controls the amount of power. A profile of power delivered can be incorporated in controller 38, and a preset amount of energy to be delivered can also be profiled.
  • Circuitry, software and feedback to [0066] controller 38 result in process control, and the maintenance of the selected power, and are used to change, (i) the selected power, including RF, microwave, laser and the like, (ii) the duty cycle (on-off and wattage), (iii) bipolar or monopolar energy delivery and (iv) infusion medium delivery, including flow rate and pressure. These process variables are controlled and varied, while maintaining the desired delivery of power independent of changes in voltage or current, based on temperatures monitored at sensors 24.
  • Referring now to FIG. 10, [0067] current sensor 30 and voltage sensor 32 are connected to the input of an analog amplifier 44. Analog amplifier 44 can be a conventional differential amplifier circuit for use with sensors 24. The output of analog amplifier 44 is sequentially connected by an analog multiplexer 46 to the input of A/D converter 48. The output of analog amplifier 44 is a voltage which represents the respective sensed temperatures. Digitized amplifier output voltages are supplied by A/D converter 48 to a microprocessor 50. Microprocessor 50 may be Model No. 68HCII available from Motorola. However, it will be appreciated that any suitable microprocessor or general purpose digital or analog computer can be used to calculate impedance or temperature.
  • [0068] Microprocessor 50 sequentially receives and stores digital representations of impedance and temperature. Each digital value received by microprocessor 50 corresponds to different temperatures and impedances.
  • Calculated power and impedance values can be indicated on user interface and [0069] display 36. Alternatively, or in addition to the numerical indication of power or impedance, calculated impedance and power values can be compared by microprocessor 50 with power and impedance limits. When the values exceed predetermined power or impedance values, a warning can be given on user interface and display 36, and additionally, the delivery of RF energy can be reduced, modified or interrupted. A control signal from microprocessor 50 can modify the power level supplied by electromagnetic energy source 20.
  • The foregoing description of a preferred embodiment of the invention has been presented for purposes of illustration and description. It is not intended to be exhaustive or to limit the invention to the precise forms disclosed. Obviously, many modifications and variations will be apparent to practitioners skilled in this art. It is intended that the scope of the invention be defined by the following claims and their equivalents.[0070]

Claims (18)

What is claimed is:
1. An cell necrosis apparatus, comprising:
a flexible introducer including a lumen and a distal end sufficiently sharp to penetrate tissue;
an energy delivery device including a first RF electrode with a tissue piercing distal portion and a second RF electrode with a tissue piercing distal portion, the first and second RF electrodes being positionable in the introducer as the introducer and deployable with curvature from the introducer and exhibiting a changing direction of travel as advanced to a selected tissue site, wherein the first and second RF electrodes exhibit at the selected tissue site a first curved section and a second curved section.
2. The apparatus of claim 1, further comprising:
a rigid electrode advancement member coupled to the energy delivery device.
3. The apparatus of claim 1, wherein the first and second RF electrodes exhibit at the selected tissue the first curved section, the second section and a linear section coupled to the first and second curved sections.
4. The apparatus of claim 1, further comprising:
an insulator positioned in a surrounding relation to at least a portion of the introducer.
5. The apparatus of claim 1, further comprising:
a sensor coupled to the first RF electrode.
6. The apparatus of claim 5, wherein the sensor is a thermal sensor..
7. The apparatus of claim 1, further comprising:
a sensor coupled to the introducer.
8. The apparatus of claim 7, further comprising:
a feedback control coupled to the sensor and to the first RF electrode.
9. The apparatus of claim 1, further comprising:
an impedance measurement apparatus coupled to the energy delivery device.
10. An cell necrosis apparatus, comprising:
an obturator including an obturator lumen and tissue piercing distal end;
a flexible introducer positionable in the obturator lumen;
an energy delivery device including a first RF electrode with a tissue piercing distal portion and a second RF electrode with a tissue piercing distal portion, the first and second RF electrodes being positionable in the introducer as the introducer and deployable with curvature from the introducer and exhibiting a changing direction of travel as advanced to a selected tissue site, wherein the first and second RF electrodes exhibit at the selected tissue site a first curved section and a second curved section.
11. The apparatus of claim 10, further comprising:
a rigid electrode advancement member coupled to the energy delivery device.
12. The apparatus of claim 10, wherein the first and second RF electrodes exhibit at the selected tissue the first curved section, the second section and a linear section coupled to the first and second curved sections.
13. The apparatus of claim 10, further comprising:
an insulator positioned in a surrounding relation to at least a portion of the introducer.
14. The apparatus of claim 10, further comprising:
a sensor coupled to the first RF electrode.
15. The apparatus of claim 14, wherein the sensor is a thermal sensor.
16. The apparatus of 10, further comprising:
a sensor coupled to the introducer.
17. The apparatus of claim 16, further comprising:
a feedback control coupled to the sensor and to the first RF electrode.
18. The apparatus of claim 10, further comprising:
an impedance measurement apparatus coupled to the energy delivery device.
US09/376,757 1995-08-15 1999-08-17 Cell necrosis apparatus Abandoned US20020026185A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US09/376,757 US20020026185A1 (en) 1995-08-15 1999-08-17 Cell necrosis apparatus

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US08/515,379 US5683384A (en) 1993-11-08 1995-08-15 Multiple antenna ablation apparatus
US08/605,323 US5728143A (en) 1995-08-15 1996-02-14 Multiple antenna ablation apparatus and method
US08/963,239 US6958062B1 (en) 1993-11-08 1997-11-03 Multiple antenna ablation apparatus and method
US09/020,182 US6132425A (en) 1995-08-15 1998-02-06 Cell necrosis apparatus
US09/028,436 US6080150A (en) 1995-08-15 1998-02-24 Cell necrosis apparatus
US09/376,757 US20020026185A1 (en) 1995-08-15 1999-08-17 Cell necrosis apparatus

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US09/028,436 Continuation US6080150A (en) 1995-08-15 1998-02-24 Cell necrosis apparatus

Publications (1)

Publication Number Publication Date
US20020026185A1 true US20020026185A1 (en) 2002-02-28

Family

ID=27533860

Family Applications (3)

Application Number Title Priority Date Filing Date
US09/028,436 Expired - Lifetime US6080150A (en) 1995-08-15 1998-02-24 Cell necrosis apparatus
US09/376,757 Abandoned US20020026185A1 (en) 1995-08-15 1999-08-17 Cell necrosis apparatus
US09/443,946 Expired - Fee Related US6652516B1 (en) 1995-08-15 1999-11-19 Cell necrosis apparatus

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US09/028,436 Expired - Lifetime US6080150A (en) 1995-08-15 1998-02-24 Cell necrosis apparatus

Family Applications After (1)

Application Number Title Priority Date Filing Date
US09/443,946 Expired - Fee Related US6652516B1 (en) 1995-08-15 1999-11-19 Cell necrosis apparatus

Country Status (1)

Country Link
US (3) US6080150A (en)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003086533A1 (en) * 2002-04-10 2003-10-23 Scimed Life Systems, Inc. Auto advancing radio frequency array
US20050228374A1 (en) * 2002-05-27 2005-10-13 Kai Desinger Therapy apparatus for thermal sclerosing of body tissue
US20070112875A1 (en) * 2004-07-15 2007-05-17 Hitachi, Ltd. Method and apparatus for hierarchical storage management based on data value and user interest
WO2007112237A2 (en) * 2006-03-24 2007-10-04 Ionatron, Inc. Barrier piercing electrode
US20110213356A1 (en) * 2009-11-05 2011-09-01 Wright Robert E Methods and systems for spinal radio frequency neurotomy
US9510905B2 (en) 2014-11-19 2016-12-06 Advanced Cardiac Therapeutics, Inc. Systems and methods for high-resolution mapping of tissue
US9517103B2 (en) 2014-11-19 2016-12-13 Advanced Cardiac Therapeutics, Inc. Medical instruments with multiple temperature sensors
US9636164B2 (en) 2015-03-25 2017-05-02 Advanced Cardiac Therapeutics, Inc. Contact sensing systems and methods
US9993178B2 (en) 2016-03-15 2018-06-12 Epix Therapeutics, Inc. Methods of determining catheter orientation
US10166062B2 (en) 2014-11-19 2019-01-01 Epix Therapeutics, Inc. High-resolution mapping of tissue with pacing
US10716618B2 (en) 2010-05-21 2020-07-21 Stratus Medical, LLC Systems and methods for tissue ablation
US10888373B2 (en) 2017-04-27 2021-01-12 Epix Therapeutics, Inc. Contact assessment between an ablation catheter and tissue

Families Citing this family (122)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050101944A1 (en) * 1983-06-27 2005-05-12 Williams Jason R. Laser radiofrequency hybrid ablation needle
US6080150A (en) * 1995-08-15 2000-06-27 Rita Medical Systems, Inc. Cell necrosis apparatus
US6530923B1 (en) * 1998-02-10 2003-03-11 Artemis Medical, Inc. Tissue removal methods and apparatus
US6592559B1 (en) * 1998-12-09 2003-07-15 Cook Incorporated Hollow, curved, superlastic medical needle
US6306132B1 (en) 1999-06-17 2001-10-23 Vivant Medical Modular biopsy and microwave ablation needle delivery apparatus adapted to in situ assembly and method of use
US7520877B2 (en) * 2000-06-07 2009-04-21 Wisconsin Alumni Research Foundation Radiofrequency ablation system using multiple prong probes
US8486065B2 (en) * 2000-06-07 2013-07-16 Wisconsin Alumni Research Foundation Radio-frequency ablation system and method using multiple electrodes
US6638277B2 (en) * 2000-07-06 2003-10-28 Scimed Life Systems, Inc. Tumor ablation needle with independently activated and independently traversing tines
US6962587B2 (en) * 2000-07-25 2005-11-08 Rita Medical Systems, Inc. Method for detecting and treating tumors using localized impedance measurement
EP1370186B1 (en) * 2001-02-28 2006-01-18 Rex Medical, L.P. Apparatus for delivering ablation fluid to treat neoplasms
US7087040B2 (en) 2001-02-28 2006-08-08 Rex Medical, L.P. Apparatus for delivering ablation fluid to treat lesions
US6989004B2 (en) 2001-02-28 2006-01-24 Rex Medical, L.P. Apparatus for delivering ablation fluid to treat lesions
US7160296B2 (en) * 2001-05-10 2007-01-09 Rita Medical Systems, Inc. Tissue ablation apparatus and method
US20030093007A1 (en) * 2001-10-17 2003-05-15 The Government Of The U.S.A., As Represented By The Secretary, Department Of Health And Human Serv Biopsy apparatus with radio frequency cauterization and methods for its use
US10285694B2 (en) 2001-10-20 2019-05-14 Covidien Lp Surgical stapler with timer and feedback display
US7464847B2 (en) 2005-06-03 2008-12-16 Tyco Healthcare Group Lp Surgical stapler with timer and feedback display
US6878147B2 (en) 2001-11-02 2005-04-12 Vivant Medical, Inc. High-strength microwave antenna assemblies
US7128739B2 (en) 2001-11-02 2006-10-31 Vivant Medical, Inc. High-strength microwave antenna assemblies and methods of use
US6752767B2 (en) 2002-04-16 2004-06-22 Vivant Medical, Inc. Localization element with energized tip
US7197363B2 (en) 2002-04-16 2007-03-27 Vivant Medical, Inc. Microwave antenna having a curved configuration
US10130415B2 (en) * 2002-06-10 2018-11-20 Wisconsin Alumni Research Foundation Circumferential electrode array for tissue ablation
US20040077951A1 (en) * 2002-07-05 2004-04-22 Wei-Chiang Lin Apparatus and methods of detection of radiation injury using optical spectroscopy
WO2004028353A2 (en) * 2002-09-30 2004-04-08 Vanderbilt University Optical apparatus for guided liver tumor treatment and methods
US20050119548A1 (en) * 2002-07-05 2005-06-02 Vanderbilt University Method and apparatus for optical spectroscopic detection of cell and tissue death
US7311703B2 (en) 2003-07-18 2007-12-25 Vivant Medical, Inc. Devices and methods for cooling microwave antennas
US20050059964A1 (en) * 2003-09-12 2005-03-17 Fitz William R. Enhancing the effectiveness of medial branch nerve root RF neurotomy
US20050190982A1 (en) * 2003-11-28 2005-09-01 Matsushita Electric Industrial Co., Ltd. Image reducing device and image reducing method
US20050245920A1 (en) * 2004-04-30 2005-11-03 Vitullo Jeffrey M Cell necrosis apparatus with cooled microwave antenna
US7670282B2 (en) 2004-06-14 2010-03-02 Pneumrx, Inc. Lung access device
EP1781182B1 (en) 2004-07-08 2019-11-13 PneumRx, Inc. Pleural effusion treatment device
US7766891B2 (en) 2004-07-08 2010-08-03 Pneumrx, Inc. Lung device with sealing features
US7261710B2 (en) * 2004-10-13 2007-08-28 Medtronic, Inc. Transurethral needle ablation system
US7335197B2 (en) * 2004-10-13 2008-02-26 Medtronic, Inc. Transurethral needle ablation system with flexible catheter tip
US7261709B2 (en) 2004-10-13 2007-08-28 Medtronic, Inc. Transurethral needle ablation system with automatic needle retraction
US20060079881A1 (en) * 2004-10-13 2006-04-13 Christopherson Mark A Single-use transurethral needle ablation
JP4874259B2 (en) 2004-11-23 2012-02-15 ヌームアールエックス・インコーポレーテッド Steerable device for accessing the target site
US7156570B2 (en) * 2004-12-30 2007-01-02 Cotapaxi Custom Design And Manufacturing, Llc Implement grip
US7918795B2 (en) 2005-02-02 2011-04-05 Gynesonics, Inc. Method and device for uterine fibroid treatment
US7799019B2 (en) 2005-05-10 2010-09-21 Vivant Medical, Inc. Reinforced high strength microwave antenna
CA2609970C (en) 2005-06-03 2014-08-12 Tyco Healthcare Group Lp Battery powered surgical instrument
US11291443B2 (en) 2005-06-03 2022-04-05 Covidien Lp Surgical stapler with timer and feedback display
US7794458B2 (en) * 2005-07-22 2010-09-14 Boston Scientific Scimed, Inc. Bipolar radio frequency ablation device with retractable insulator
US20090177111A1 (en) * 2006-12-06 2009-07-09 Miller Stephan P System and method for displaying contact between a catheter and tissue
US7874986B2 (en) 2006-04-20 2011-01-25 Gynesonics, Inc. Methods and devices for visualization and ablation of tissue
US9357977B2 (en) 2006-01-12 2016-06-07 Gynesonics, Inc. Interventional deployment and imaging system
US10058342B2 (en) 2006-01-12 2018-08-28 Gynesonics, Inc. Devices and methods for treatment of tissue
US7815571B2 (en) 2006-04-20 2010-10-19 Gynesonics, Inc. Rigid delivery systems having inclined ultrasound and needle
US11259825B2 (en) 2006-01-12 2022-03-01 Gynesonics, Inc. Devices and methods for treatment of tissue
US20070179491A1 (en) * 2006-01-31 2007-08-02 Medtronic, Inc. Sensing needle for ablation therapy
US8157837B2 (en) 2006-03-13 2012-04-17 Pneumrx, Inc. Minimally invasive lung volume reduction device and method
US8888800B2 (en) 2006-03-13 2014-11-18 Pneumrx, Inc. Lung volume reduction devices, methods, and systems
US9402633B2 (en) 2006-03-13 2016-08-02 Pneumrx, Inc. Torque alleviating intra-airway lung volume reduction compressive implant structures
US10595819B2 (en) 2006-04-20 2020-03-24 Gynesonics, Inc. Ablation device with articulated imaging transducer
US8206300B2 (en) 2008-08-26 2012-06-26 Gynesonics, Inc. Ablation device with articulated imaging transducer
US20100056926A1 (en) * 2008-08-26 2010-03-04 Gynesonics, Inc. Ablation device with articulated imaging transducer
US20080221650A1 (en) * 2006-08-04 2008-09-11 Turner Paul F Microwave applicator with adjustable heating length
US20080033422A1 (en) * 2006-08-04 2008-02-07 Turner Paul F Microwave applicator with margin temperature sensing element
WO2008034100A2 (en) 2006-09-14 2008-03-20 Lazure Technologies, Llc Ablation probe with deployable electrodes
US8048069B2 (en) 2006-09-29 2011-11-01 Medtronic, Inc. User interface for ablation therapy
US8068921B2 (en) 2006-09-29 2011-11-29 Vivant Medical, Inc. Microwave antenna assembly and method of using the same
US8211099B2 (en) 2007-01-31 2012-07-03 Tyco Healthcare Group Lp Thermal feedback systems and methods of using the same
US7431188B1 (en) 2007-03-15 2008-10-07 Tyco Healthcare Group Lp Surgical stapling apparatus with powered articulation
US8800837B2 (en) 2007-04-13 2014-08-12 Covidien Lp Powered surgical instrument
US11259801B2 (en) 2007-04-13 2022-03-01 Covidien Lp Powered surgical instrument
US7950560B2 (en) 2007-04-13 2011-05-31 Tyco Healthcare Group Lp Powered surgical instrument
US20080255413A1 (en) 2007-04-13 2008-10-16 Michael Zemlok Powered surgical instrument
US7998139B2 (en) 2007-04-25 2011-08-16 Vivant Medical, Inc. Cooled helical antenna for microwave ablation
US8945114B2 (en) 2007-04-26 2015-02-03 Medtronic, Inc. Fluid sensor for ablation therapy
US8814856B2 (en) * 2007-04-30 2014-08-26 Medtronic, Inc. Extension and retraction mechanism for a hand-held device
US7823760B2 (en) 2007-05-01 2010-11-02 Tyco Healthcare Group Lp Powered surgical stapling device platform
US20080275440A1 (en) * 2007-05-03 2008-11-06 Medtronic, Inc. Post-ablation verification of lesion size
US7931660B2 (en) 2007-05-10 2011-04-26 Tyco Healthcare Group Lp Powered tacker instrument
US8353901B2 (en) * 2007-05-22 2013-01-15 Vivant Medical, Inc. Energy delivery conduits for use with electrosurgical devices
US9186207B2 (en) * 2007-06-14 2015-11-17 Medtronic, Inc. Distal viewing window of a medical catheter
US8845630B2 (en) 2007-06-15 2014-09-30 Syneron Medical Ltd Devices and methods for percutaneous energy delivery
US20080312647A1 (en) * 2007-06-15 2008-12-18 Primaeva Medical, Inc. Methods and devices for treating tissue
US9023024B2 (en) 2007-06-20 2015-05-05 Covidien Lp Reflective power monitoring for microwave applications
US20090005766A1 (en) * 2007-06-28 2009-01-01 Joseph Brannan Broadband microwave applicator
US8651146B2 (en) 2007-09-28 2014-02-18 Covidien Lp Cable stand-off
US8088072B2 (en) 2007-10-12 2012-01-03 Gynesonics, Inc. Methods and systems for controlled deployment of needles in tissue
US7922063B2 (en) 2007-10-31 2011-04-12 Tyco Healthcare Group, Lp Powered surgical instrument
US8292880B2 (en) 2007-11-27 2012-10-23 Vivant Medical, Inc. Targeted cooling of deployable microwave antenna
US9173669B2 (en) 2008-09-12 2015-11-03 Pneumrx, Inc. Enhanced efficacy lung volume reduction devices, methods, and systems
US8262574B2 (en) 2009-02-27 2012-09-11 Gynesonics, Inc. Needle and tine deployment mechanism
CN104622599B (en) 2009-05-18 2017-04-12 纽姆克斯股份有限公司 Cross-sectional modification during deployment of an elongate lung volume reduction device
US8821514B2 (en) 2009-06-08 2014-09-02 Covidien Lp Powered tack applier
US8298187B2 (en) 2009-07-07 2012-10-30 Cook Medical Technologies Llc Fluid injection device
US10828100B2 (en) * 2009-08-25 2020-11-10 Covidien Lp Microwave ablation with tissue temperature monitoring
US20110125148A1 (en) * 2009-11-17 2011-05-26 Turner Paul F Multiple Frequency Energy Supply and Coagulation System
US8551083B2 (en) 2009-11-17 2013-10-08 Bsd Medical Corporation Microwave coagulation applicator and system
US9993294B2 (en) * 2009-11-17 2018-06-12 Perseon Corporation Microwave coagulation applicator and system with fluid injection
US8414570B2 (en) * 2009-11-17 2013-04-09 Bsd Medical Corporation Microwave coagulation applicator and system
ES2703556T3 (en) 2011-10-15 2019-03-11 Diros Tech Inc Apparatus for accurately controlling the size and shape of radiofrequency ablation
US10076383B2 (en) 2012-01-25 2018-09-18 Covidien Lp Electrosurgical device having a multiplexer
EP2633876B1 (en) 2012-03-02 2014-09-24 Cook Medical Technologies LLC Dilation cap for endoluminal device
WO2013172361A1 (en) * 2012-05-14 2013-11-21 国立大学法人 滋賀医科大学 Organ resection tool
US9204921B2 (en) 2012-12-13 2015-12-08 Cook Medical Technologies Llc RF energy controller and method for electrosurgical medical devices
US9364277B2 (en) 2012-12-13 2016-06-14 Cook Medical Technologies Llc RF energy controller and method for electrosurgical medical devices
US20150342668A1 (en) 2013-02-21 2015-12-03 Stryker Corporation Tissue ablation cannula and elecgtrode assembly that can be selectively operated with one or more active tips
US10531916B2 (en) * 2013-11-13 2020-01-14 Micron Shiga Inc. Microwave-irradiating instrument
US9855402B2 (en) 2014-02-15 2018-01-02 Rex Medical, L.P. Apparatus for delivering fluid to treat renal hypertension
CA2948009C (en) * 2014-05-04 2021-07-27 Diros Technology Inc. Radiofrequency probes with retractable multi-tined electrodes
US10799283B2 (en) 2014-07-28 2020-10-13 Boston Scientific Scimed, Inc. Multiple lead electrode probe for controlled tissue ablation
US10390838B1 (en) 2014-08-20 2019-08-27 Pneumrx, Inc. Tuned strength chronic obstructive pulmonary disease treatment
JP7237829B2 (en) 2016-11-11 2023-03-13 ガイネソニックス， インコーポレイテッド Dynamic interaction of tissue controlled treatment with tissue and/or treatment data and their comparison
US11311295B2 (en) 2017-05-15 2022-04-26 Covidien Lp Adaptive powered stapling algorithm with calibration factor
US11207066B2 (en) 2017-10-30 2021-12-28 Covidien Lp Apparatus for endoscopic procedures
US10987104B2 (en) 2017-10-30 2021-04-27 Covidien Lp Apparatus for endoscopic procedures
US11497490B2 (en) 2018-07-09 2022-11-15 Covidien Lp Powered surgical devices including predictive motor control
US11197734B2 (en) 2018-10-30 2021-12-14 Covidien Lp Load sensing devices for use in surgical instruments
US11369372B2 (en) 2018-11-28 2022-06-28 Covidien Lp Surgical stapler adapter with flexible cable assembly, flexible fingers, and contact clips
US11202635B2 (en) 2019-02-04 2021-12-21 Covidien Lp Programmable distal tilt position of end effector for powered surgical devices
US11376006B2 (en) 2019-02-06 2022-07-05 Covidien Lp End effector force measurement with digital drive circuit
US11219461B2 (en) 2019-03-08 2022-01-11 Covidien Lp Strain gauge stabilization in a surgical device
US11458244B2 (en) 2020-02-07 2022-10-04 Covidien Lp Irrigating surgical apparatus with positive pressure fluid
US11553913B2 (en) 2020-02-11 2023-01-17 Covidien Lp Electrically-determining tissue cut with surgical stapling apparatus
US11622768B2 (en) 2020-07-13 2023-04-11 Covidien Lp Methods and structure for confirming proper assembly of powered surgical stapling systems
US11653919B2 (en) 2020-11-24 2023-05-23 Covidien Lp Stapler line reinforcement continuity
US11744580B2 (en) 2020-11-24 2023-09-05 Covidien Lp Long stapler reloads with continuous cartridge
US11684362B2 (en) 2021-06-07 2023-06-27 Covidien Lp Handheld electromechanical surgical system
US11771432B2 (en) 2021-06-29 2023-10-03 Covidien Lp Stapling and cutting to default values in the event of strain gauge data integrity loss
US11832823B2 (en) 2022-02-08 2023-12-05 Covidien Lp Determination of anvil release during anastomosis

Family Cites Families (234)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US32057A (en) * 1861-04-16 Joint of railboad-bails
US32066A (en) * 1861-04-16 Apparatus for supplying steam-boilers with water
US34086A (en) * 1862-01-07 Improvement in boots or shoes
US3474777A (en) * 1966-02-10 1969-10-28 Amp Inc Method of administering therapeutic agents
US3858586A (en) * 1971-03-11 1975-01-07 Martin Lessen Surgical method and electrode therefor
US3834392A (en) * 1973-02-01 1974-09-10 Kli Inc Laparoscopy system
US4016881A (en) * 1973-07-04 1977-04-12 Centre De Recherche Industrielle Du Quebec Instrument for use in laparoscopic tubal cauterization
US3991770A (en) * 1974-01-24 1976-11-16 Leveen Harry H Method for treating benign and malignant tumors utilizing radio frequency, electromagnetic radiation
DE2513868C2 (en) * 1974-04-01 1982-11-04 Olympus Optical Co., Ltd., Tokyo Bipolar electrodiathermy forceps
US4033351A (en) * 1974-06-14 1977-07-05 Siemens Aktiengesellschaft Bipolar cutting electrode for high-frequency surgery
US4303636A (en) * 1974-08-20 1981-12-01 Gordon Robert T Cancer treatment
US4043342A (en) * 1974-08-28 1977-08-23 Valleylab, Inc. Electrosurgical devices having sesquipolar electrode structures incorporated therein
US3987795A (en) * 1974-08-28 1976-10-26 Valleylab, Inc. Electrosurgical devices having sesquipolar electrode structures incorporated therein
US4016886A (en) * 1974-11-26 1977-04-12 The United States Of America As Represented By The United States Energy Research And Development Administration Method for localizing heating in tumor tissue
US4026301A (en) * 1975-04-21 1977-05-31 Medtronic, Inc. Apparatus and method for optimum electrode placement in the treatment of disease syndromes such as spinal curvature
US4000743A (en) * 1975-07-09 1977-01-04 Kenneth Weaver Uterine anteverter
US4119102A (en) 1975-07-11 1978-10-10 Leveen Harry H Radio frequency treatment of tumors while inducing hypotension
US4230129A (en) * 1975-07-11 1980-10-28 Leveen Harry H Radio frequency, electromagnetic radiation device having orbital mount
US4121592A (en) * 1975-08-04 1978-10-24 Critical Systems, Inc. Apparatus for heating tissue
US4074718A (en) * 1976-03-17 1978-02-21 Valleylab, Inc. Electrosurgical instrument
US4080959A (en) * 1976-06-18 1978-03-28 Leveen Robert F Method for detection of tumors of the breast
US4095602A (en) * 1976-09-27 1978-06-20 Leveen Harry H Multi-portal radiofrequency generator
US4140130A (en) * 1977-05-31 1979-02-20 Storm Iii Frederick K Electrode structure for radio frequency localized heating of tumor bearing tissue
US4154246A (en) * 1977-07-25 1979-05-15 Leveen Harry H Field intensification in radio frequency thermotherapy
US4237898A (en) * 1978-03-27 1980-12-09 Critical Systems, Inc. Apparatus for heating tissue and employing protection against transients
US4346715A (en) * 1978-07-12 1982-08-31 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Hyperthermia heating apparatus
US4337760A (en) * 1978-10-13 1982-07-06 Adolf Schwimmer Method for the treatment of tumors with β-glucuronidase activity dependent pharmaceuticals
US4418692A (en) * 1978-11-17 1983-12-06 Guay Jean Louis Device for treating living tissue with an electric current
SE418248B (en) * 1978-11-23 1981-05-18 Tekniska Roentgencentralen Ab DEVICE FOR DESTRUCTING A BIOLOGICAL TISSUE PARTY
US4285346A (en) * 1979-03-14 1981-08-25 Harry V. LeVeen Electrode system
US4345588A (en) * 1979-04-23 1982-08-24 Northwestern University Method of delivering a therapeutic agent to a target capillary bed
US4269174A (en) * 1979-08-06 1981-05-26 Medical Dynamics, Inc. Transcutaneous vasectomy apparatus and method
US4290435A (en) * 1979-09-07 1981-09-22 Thermatime A.G. Internally cooled electrode for hyperthermal treatment and method of use
US4375220A (en) * 1980-05-09 1983-03-01 Matvias Fredrick M Microwave applicator with cooling mechanism for intracavitary treatment of cancer
WO1981003271A1 (en) * 1980-05-13 1981-11-26 American Hospital Supply Corp A multipolar electrosurgical device
US4331654A (en) * 1980-06-13 1982-05-25 Eli Lilly And Company Magnetically-localizable, biodegradable lipid microspheres
JPS5725863A (en) * 1980-07-23 1982-02-10 Olympus Optical Co Endoscope with microwave heater
US4411266A (en) * 1980-09-24 1983-10-25 Cosman Eric R Thermocouple radio frequency lesion electrode
US4565200A (en) * 1980-09-24 1986-01-21 Cosman Eric R Universal lesion and recording electrode system
JPS57168656A (en) * 1981-04-10 1982-10-18 Medos Kenkyusho Kk Endoscope laser coagulator
US4562383A (en) * 1981-07-31 1985-12-31 Siemens Aktiengesellschaft Converter
US4574782A (en) * 1981-11-16 1986-03-11 Corning Glass Works Radio frequency-induced hyperthermia for tumor therapy
US5435805A (en) 1992-08-12 1995-07-25 Vidamed, Inc. Medical probe device with optical viewing capability
US5370675A (en) 1992-08-12 1994-12-06 Vidamed, Inc. Medical probe device and method
US5421819A (en) 1992-08-12 1995-06-06 Vidamed, Inc. Medical probe device
US5385544A (en) 1992-08-12 1995-01-31 Vidamed, Inc. BPH ablation method and apparatus
US5542915A (en) 1992-08-12 1996-08-06 Vidamed, Inc. Thermal mapping catheter with ultrasound probe
US4512762A (en) * 1982-11-23 1985-04-23 The Beth Israel Hospital Association Method of treatment of atherosclerosis and a balloon catheter for same
US4583556A (en) * 1982-12-13 1986-04-22 M/A-Com, Inc. Microwave applicator/receiver apparatus
US4961422A (en) 1983-01-21 1990-10-09 Marchosky J Alexander Method and apparatus for volumetric interstitial conductive hyperthermia
CA1244889A (en) * 1983-01-24 1988-11-15 Kureha Chemical Ind Co Ltd Device for hyperthermia
US4524770A (en) * 1983-01-25 1985-06-25 Ahmad Orandi Endoscope injection needle
US4506680A (en) * 1983-03-17 1985-03-26 Medtronic, Inc. Drug dispensing body implantable lead
US4545368A (en) * 1983-04-13 1985-10-08 Rand Robert W Induction heating method for use in causing necrosis of neoplasm
US4662359A (en) * 1983-08-12 1987-05-05 Robert T. Gordon Use of magnetic susceptibility probes in the treatment of cancer
JPS6055966A (en) * 1983-09-05 1985-04-01 オリンパス光学工業株式会社 Medical electrode apparatus
US4658819A (en) * 1983-09-13 1987-04-21 Valleylab, Inc. Electrosurgical generator
US4601296A (en) * 1983-10-07 1986-07-22 Yeda Research And Development Co., Ltd. Hyperthermia apparatus
US4818542A (en) * 1983-11-14 1989-04-04 The University Of Kentucky Research Foundation Porous microspheres for drug delivery and methods for making same
EP0165993A1 (en) * 1983-12-27 1986-01-02 The Board Of Trustees Of The Leland Stanford Junior University Catheter for treatment of tumors and method for using same
US4586490A (en) * 1984-02-27 1986-05-06 Katz Harry R Needle inserting instrument means for interstitial radiotherapy
CA1237482A (en) * 1984-03-09 1988-05-31 Frank B. Stiles Catheter for effecting removal of obstructions from a biological duct
US4800899A (en) * 1984-10-22 1989-01-31 Microthermia Technology, Inc. Apparatus for destroying cells in tumors and the like
US4652257A (en) * 1985-03-21 1987-03-24 The United States Of America As Represented By The Secretary Of The Navy Magnetically-localizable, polymerized lipid vesicles and method of disrupting same
US4648892A (en) * 1985-03-22 1987-03-10 Massachusetts Institute Of Technology Method for making optical shield for a laser catheter
US4983159A (en) * 1985-03-25 1991-01-08 Rand Robert W Inductive heating process for use in causing necrosis of neoplasms at selective frequencies
US4838265A (en) * 1985-05-24 1989-06-13 Cosman Eric R Localization device for probe placement under CT scanner imaging
US4660571A (en) * 1985-07-18 1987-04-28 Cordis Corporation Percutaneous lead having radially adjustable electrode
US4823793A (en) * 1985-10-30 1989-04-25 The United States Of America As Represented By The Administrator Of The National Aeronuautics & Space Administration Cutting head for ultrasonic lithotripsy
US4690130A (en) * 1985-12-19 1987-09-01 Mirell Stuart G Electromagnetic therapy control system
SE455920B (en) * 1986-01-29 1988-08-22 Hans Wiksell TUMOR HYPERTERMY TREATMENT DEVICE
US4700716A (en) * 1986-02-27 1987-10-20 Kasevich Associates, Inc. Collinear antenna array applicator
US4709701A (en) * 1986-04-15 1987-12-01 Medical Research & Development Associates Apparatus for medical treatment by hyperthermia
IL78756A0 (en) * 1986-05-12 1986-08-31 Biodan Medical Systems Ltd Catheter and probe
NL8601808A (en) 1986-07-10 1988-02-01 Hooft Eric T METHOD FOR TREATING A BODY PART WITH RADIOACTIVE MATERIAL AND CART USED THEREIN
US4940064A (en) * 1986-11-14 1990-07-10 Desai Jawahar M Catheter for mapping and ablation and method therefor
US5365926A (en) 1986-11-14 1994-11-22 Desai Jawahar M Catheter for mapping and ablation and method therefor
US5231995A (en) 1986-11-14 1993-08-03 Desai Jawahar M Method for catheter mapping and ablation
US5215103A (en) 1986-11-14 1993-06-01 Desai Jawahar M Catheter for mapping and ablation and method therefor
US4962761A (en) * 1987-02-24 1990-10-16 Golden Theodore A Thermal bandage
US5003991A (en) * 1987-03-31 1991-04-02 Olympus Optical Co., Ltd. Hyperthermia apparatus
US4823791A (en) * 1987-05-08 1989-04-25 Circon Acmi Division Of Circon Corporation Electrosurgical probe apparatus
DE3718139C1 (en) * 1987-05-29 1988-12-08 Strahlen Umweltforsch Gmbh Cardiac catheter
US5170789A (en) 1987-06-17 1992-12-15 Perinchery Narayan Insertable NMR coil probe
US4825880A (en) * 1987-06-19 1989-05-02 The Regents Of The University Of California Implantable helical coil microwave antenna
US4753248A (en) * 1987-06-24 1988-06-28 Duke University Probe translation system for use in hyperthermia treatment
US5015227A (en) * 1987-09-30 1991-05-14 Valleylab Inc. Apparatus for providing enhanced tissue fragmentation and/or hemostasis
US4931047A (en) * 1987-09-30 1990-06-05 Cavitron, Inc. Method and apparatus for providing enhanced tissue fragmentation and/or hemostasis
US4860744A (en) * 1987-11-02 1989-08-29 Raj K. Anand Thermoelectrically controlled heat medical catheter
JPH01139081A (en) * 1987-11-27 1989-05-31 Olympus Optical Co Ltd Apparatus for radiating laser beam
US4907589A (en) * 1988-04-29 1990-03-13 Cosman Eric R Automatic over-temperature control apparatus for a therapeutic heating device
US4989601A (en) * 1988-05-02 1991-02-05 Medical Engineering & Development Institute, Inc. Method, apparatus, and substance for treating tissue having neoplastic cells
US5178620A (en) 1988-06-10 1993-01-12 Advanced Angioplasty Products, Inc. Thermal dilatation catheter and method
US4881543A (en) * 1988-06-28 1989-11-21 Massachusetts Institute Of Technology Combined microwave heating and surface cooling of the cornea
US5249585A (en) 1988-07-28 1993-10-05 Bsd Medical Corporation Urethral inserted applicator for prostate hyperthermia
US4967765A (en) 1988-07-28 1990-11-06 Bsd Medical Corporation Urethral inserted applicator for prostate hyperthermia
US4920978A (en) * 1988-08-31 1990-05-01 Triangle Research And Development Corporation Method and apparatus for the endoscopic treatment of deep tumors using RF hyperthermia
US4947842A (en) * 1988-09-22 1990-08-14 Medical Engineering And Development Institute, Inc. Method and apparatus for treating tissue with first and second modalities
US4976680A (en) * 1988-10-07 1990-12-11 Hayman Michael H Apparatus for in situ radiotherapy
US5183455A (en) 1988-10-07 1993-02-02 Omnitron International, Inc. Apparatus for in situ radiotherapy
US5026959A (en) * 1988-11-16 1991-06-25 Tokyo Keiki Co. Ltd. Microwave radiator for warming therapy
FR2639238B1 (en) 1988-11-21 1991-02-22 Technomed Int Sa APPARATUS FOR SURGICAL TREATMENT OF TISSUES BY HYPERTHERMIA, PREFERABLY THE PROSTATE, COMPRISING MEANS OF THERMAL PROTECTION COMPRISING PREFERABLY RADIOREFLECTIVE SCREEN MEANS
US4985022A (en) * 1988-11-23 1991-01-15 Med Institute, Inc. Catheter having durable and flexible segments
US4945912A (en) * 1988-11-25 1990-08-07 Sensor Electronics, Inc. Catheter with radiofrequency heating applicator
US5205289A (en) 1988-12-23 1993-04-27 Medical Instrumentation And Diagnostics Corporation Three-dimensional computer graphics simulation and computerized numerical optimization for dose delivery and treatment planning
US5128147A (en) 1989-01-06 1992-07-07 Thermal Developments, Inc. Heat intensifier and localizer for radiofrequency thermotherapy
US4966604A (en) * 1989-01-23 1990-10-30 Interventional Technologies Inc. Expandable atherectomy cutter with flexibly bowed blades
USRE34086E (en) 1989-02-27 1992-10-06 Medical placement device
US4963364A (en) * 1989-04-10 1990-10-16 Fox Sidney W Microencapsulated antitumor agent
US5059199A (en) 1989-04-12 1991-10-22 Olympus Optical Co., Ltd. Treating device for endoscopes
US5057107A (en) * 1989-04-13 1991-10-15 Everest Medical Corporation Ablation catheter with selectively deployable electrodes
US5078717A (en) 1989-04-13 1992-01-07 Everest Medical Corporation Ablation catheter with selectively deployable electrodes
US4976711A (en) * 1989-04-13 1990-12-11 Everest Medical Corporation Ablation catheter with selectively deployable electrodes
US5125928A (en) 1989-04-13 1992-06-30 Everest Medical Corporation Ablation catheter with selectively deployable electrodes
US5010897A (en) * 1989-04-26 1991-04-30 Leveen Harry H Apparatus for deep heating of cancer
US5057104A (en) 1989-05-30 1991-10-15 Cyrus Chess Method and apparatus for treating cutaneous vascular lesions
US5099756A (en) 1989-06-01 1992-03-31 Harry H. Leveen Radio frequency thermotherapy
US5055100A (en) * 1989-06-19 1991-10-08 Eugene Olsen Suction attachment for electrosurgical instruments or the like
US5011483A (en) * 1989-06-26 1991-04-30 Dennis Sleister Combined electrosurgery and laser beam delivery device
US5119832A (en) 1989-07-11 1992-06-09 Ravi Xavier Epidural catheter with nerve stimulators
US5009656A (en) * 1989-08-17 1991-04-23 Mentor O&O Inc. Bipolar electrosurgical instrument
JP3046315B2 (en) 1989-09-05 2000-05-29 株式会社エス・エル・ティ・ジャパン Laser irradiation equipment
US5007908A (en) * 1989-09-29 1991-04-16 Everest Medical Corporation Electrosurgical instrument having needle cutting electrode and spot-coag electrode
US5203353A (en) 1989-10-24 1993-04-20 Surgical Technologies, Inc. Method of penetrating and working in the vitreous humor of the eye
US5273535A (en) 1991-11-08 1993-12-28 Ep Technologies, Inc. Catheter with electrode tip having asymmetric left and right curve configurations
US5115818A (en) 1990-02-14 1992-05-26 Medtronic, Inc. Implantable electrode
US5016615A (en) * 1990-02-20 1991-05-21 Riverside Research Institute Local application of medication with ultrasound
US5013312A (en) * 1990-03-19 1991-05-07 Everest Medical Corporation Bipolar scalpel for harvesting internal mammary artery
US5067952A (en) 1990-04-02 1991-11-26 Gudov Vasily F Method and apparatus for treating malignant tumors by local hyperpyrexia
US5203782A (en) 1990-04-02 1993-04-20 Gudov Vasily F Method and apparatus for treating malignant tumors by local hyperpyrexia
JPH03297475A (en) 1990-04-16 1991-12-27 Ken Ishihara Controlling method for emission of medicine by means of resonance sound wave
US5047027A (en) * 1990-04-20 1991-09-10 Everest Medical Corporation Tumor resector
US5122137A (en) 1990-04-27 1992-06-16 Boston Scientific Corporation Temperature controlled rf coagulation
US5071419A (en) 1990-04-30 1991-12-10 Everest Medical Corporation Percutaneous laparoscopic cholecystectomy instrument
US5080660A (en) 1990-05-11 1992-01-14 Applied Urology, Inc. Electrosurgical electrode
US5169396A (en) 1990-06-08 1992-12-08 Kambiz Dowlatshahi Method for interstitial laser therapy
US5190539A (en) 1990-07-10 1993-03-02 Texas A & M University System Micro-heat-pipe catheter
US5236410A (en) 1990-08-02 1993-08-17 Ferrotherm International, Inc. Tumor treatment method
US5083565A (en) 1990-08-03 1992-01-28 Everest Medical Corporation Electrosurgical instrument for ablating endocardial tissue
US5100423A (en) 1990-08-21 1992-03-31 Medical Engineering & Development Institute, Inc. Ablation catheter
US5084045A (en) 1990-09-17 1992-01-28 Helenowski Tomasz K Suction surgical instrument
US5167626A (en) 1990-10-02 1992-12-01 Glaxo Inc. Medical capsule device actuated by radio-frequency (RF) signal
US5190541A (en) 1990-10-17 1993-03-02 Boston Scientific Corporation Surgical instrument and method
US5085659A (en) 1990-11-21 1992-02-04 Everest Medical Corporation Biopsy device with bipolar coagulation capability
US5170805A (en) 1990-12-11 1992-12-15 Kensey Nash Corporation Method of destroying tissue such as a gall bladder utilizing a sclerosing agent alone or with a symphysis agent
FR2671010B1 (en) 1990-12-27 1993-07-09 Ela Medical Sa ENDOCARDIAC PROBE PROVIDED WITH AN ACTIVE FIXING MEMBER
US5156151A (en) 1991-02-15 1992-10-20 Cardiac Pathways Corporation Endocardial mapping and ablation system and catheter probe
US5409453A (en) 1992-08-12 1995-04-25 Vidamed, Inc. Steerable medical probe with stylets
US5252922A (en) 1991-04-30 1993-10-12 Hewlett-Packard Company Radiofrequency focusing of magnetic resonance images
EP0766533A1 (en) 1991-05-17 1997-04-09 InnerDyne, Inc. Method and device for thermal ablation
US5542928A (en) 1991-05-17 1996-08-06 Innerdyne, Inc. Method and device for thermal ablation having improved heat transfer
AU1899292A (en) 1991-05-24 1993-01-08 Ep Technologies Inc Combination monophasic action potential/ablation catheter and high-performance filter system
US5190517A (en) 1991-06-06 1993-03-02 Valleylab Inc. Electrosurgical and ultrasonic surgical system
IT1247029B (en) 1991-06-19 1994-12-12 S M A Segnalamento Marittimo E MICROWAVE EQUIPMENT FOR CLINICAL HYPERTHERMIA IN ENDOGENIC THERMOTHERAPY
US5251645A (en) 1991-06-26 1993-10-12 Massachusetts Institute Of Technology Adaptive nulling hyperthermia array
US5383917A (en) 1991-07-05 1995-01-24 Jawahar M. Desai Device and method for multi-phase radio-frequency ablation
US5620481A (en) 1991-07-05 1997-04-15 Desai; Jawahar M. Device for multi-phase radio-frequency ablation
US5207675A (en) 1991-07-15 1993-05-04 Jerome Canady Surgical coagulation device
US5222953A (en) 1991-10-02 1993-06-29 Kambiz Dowlatshahi Apparatus for interstitial laser therapy having an improved temperature sensor for tissue being treated
US5562703A (en) 1994-06-14 1996-10-08 Desai; Ashvin H. Endoscopic surgical instrument
US5322503A (en) 1991-10-18 1994-06-21 Desai Ashvin H Endoscopic surgical instrument
US5328467A (en) 1991-11-08 1994-07-12 Ep Technologies, Inc. Catheter having a torque transmitting sleeve
US5257451A (en) 1991-11-08 1993-11-02 Ep Technologies, Inc. Method of making durable sleeve for enclosing a bendable electrode tip assembly
US5275162A (en) 1991-11-08 1994-01-04 Ep Technologies, Inc. Valve mapping catheter
AU3128593A (en) 1991-11-08 1993-06-07 Ep Technologies Inc Radiofrequency ablation with phase sensitive power detection
US5363861A (en) 1991-11-08 1994-11-15 Ep Technologies, Inc. Electrode tip assembly with variable resistance to bending
DE69233091T2 (en) 1991-11-08 2004-05-06 Boston Scientific Ltd., St. Michael ABLATION ELECTRODE WITH INSULATED TEMPERATURE MEASURING ELEMENT
US5197964A (en) 1991-11-12 1993-03-30 Everest Medical Corporation Bipolar instrument utilizing one stationary electrode and one movable electrode
DE4138115A1 (en) 1991-11-19 1993-05-27 Delma Elektro Med App MEDICAL HIGH FREQUENCY COAGULATION INSTRUMENT
US5197963A (en) 1991-12-02 1993-03-30 Everest Medical Corporation Electrosurgical instrument with extendable sheath for irrigation and aspiration
US5259395A (en) 1992-01-15 1993-11-09 Siemens Pacesetter, Inc. Pacemaker lead with extendable retractable lockable fixing helix
US5304214A (en) 1992-01-21 1994-04-19 Med Institute, Inc. Transurethral ablation catheter
US5267994A (en) 1992-02-10 1993-12-07 Conmed Corporation Electrosurgical probe
US5295955A (en) 1992-02-14 1994-03-22 Amt, Inc. Method and apparatus for microwave aided liposuction
US5300099A (en) 1992-03-06 1994-04-05 Urologix, Inc. Gamma matched, helical dipole microwave antenna
US5217458A (en) 1992-04-09 1993-06-08 Everest Medical Corporation Bipolar biopsy device utilizing a rotatable, single-hinged moving element
US5314466A (en) 1992-04-13 1994-05-24 Ep Technologies, Inc. Articulated unidirectional microwave antenna systems for cardiac ablation
WO1993020768A1 (en) 1992-04-13 1993-10-28 Ep Technologies, Inc. Steerable microwave antenna systems for cardiac ablation
WO1993020886A1 (en) 1992-04-13 1993-10-28 Ep Technologies, Inc. Articulated systems for cardiac ablation
US5281217A (en) 1992-04-13 1994-01-25 Ep Technologies, Inc. Steerable antenna systems for cardiac ablation that minimize tissue damage and blood coagulation due to conductive heating patterns
US5423807A (en) 1992-04-16 1995-06-13 Implemed, Inc. Cryogenic mapping and ablation catheter
US5281213A (en) 1992-04-16 1994-01-25 Implemed, Inc. Catheter for ice mapping and ablation
US5300068A (en) 1992-04-21 1994-04-05 St. Jude Medical, Inc. Electrosurgical apparatus
US5236424A (en) 1992-06-05 1993-08-17 Cardiac Pathways Corporation Catheter with retractable cannula for delivering a plurality of chemicals
US5281218A (en) 1992-06-05 1994-01-25 Cardiac Pathways Corporation Catheter having needle electrode for radiofrequency ablation
US5411025A (en) 1992-06-30 1995-05-02 Cordis Webster, Inc. Cardiovascular catheter with laterally stable basket-shaped electrode array
WO1994002077A2 (en) 1992-07-15 1994-02-03 Angelase, Inc. Ablation catheter system
US5542916A (en) 1992-08-12 1996-08-06 Vidamed, Inc. Dual-channel RF power delivery system
US5456662A (en) 1993-02-02 1995-10-10 Edwards; Stuart D. Method for reducing snoring by RF ablation of the uvula
US5300069A (en) 1992-08-12 1994-04-05 Daniel Hunsberger Electrosurgical apparatus for laparoscopic procedures and method of use
US5486161A (en) 1993-02-02 1996-01-23 Zomed International Medical probe device and method
US5514131A (en) 1992-08-12 1996-05-07 Stuart D. Edwards Method for the ablation treatment of the uvula
US5484400A (en) 1992-08-12 1996-01-16 Vidamed, Inc. Dual channel RF delivery system
US5556377A (en) 1992-08-12 1996-09-17 Vidamed, Inc. Medical probe apparatus with laser and/or microwave monolithic integrated circuit probe
US5470308A (en) 1992-08-12 1995-11-28 Vidamed, Inc. Medical probe with biopsy stylet
US5258006A (en) 1992-08-21 1993-11-02 Everest Medical Corporation Bipolar electrosurgical forceps
US5293869A (en) 1992-09-25 1994-03-15 Ep Technologies, Inc. Cardiac probe with dynamic support for maintaining constant surface contact during heart systole and diastole
US5309910A (en) 1992-09-25 1994-05-10 Ep Technologies, Inc. Cardiac mapping and ablation systems
US5401272A (en) 1992-09-25 1995-03-28 Envision Surgical Systems, Inc. Multimodality probe with extendable bipolar electrodes
US5549108A (en) 1992-09-25 1996-08-27 Ep Technologies, Inc. Cardiac mapping and ablation systems
US5313943A (en) 1992-09-25 1994-05-24 Ep Technologies, Inc. Catheters and methods for performing cardiac diagnosis and treatment
US5471982A (en) 1992-09-29 1995-12-05 Ep Technologies, Inc. Cardiac mapping and ablation systems
US5286253A (en) 1992-10-09 1994-02-15 Linvatec Corporation Angled rotating surgical instrument
US5342357A (en) 1992-11-13 1994-08-30 American Cardiac Ablation Co., Inc. Fluid cooled electrosurgical cauterization system
WO1994010924A1 (en) 1992-11-13 1994-05-26 American Cardiac Ablation Co., Inc. Fluid cooled electrosurgical probe
US5334193A (en) 1992-11-13 1994-08-02 American Cardiac Ablation Co., Inc. Fluid cooled ablation catheter
US5348554A (en) 1992-12-01 1994-09-20 Cardiac Pathways Corporation Catheter for RF ablation with cooled electrode
US5545161A (en) 1992-12-01 1996-08-13 Cardiac Pathways Corporation Catheter for RF ablation having cooled electrode with electrically insulated sleeve
JPH08506259A (en) 1993-02-02 1996-07-09 ヴィーダメッド インコーポレイテッド Transurethral needle excision device and method
US5354296A (en) 1993-03-24 1994-10-11 Symbiosis Corporation Electrocautery probe with variable morphology electrode
US5336222A (en) 1993-03-29 1994-08-09 Boston Scientific Corporation Integrated catheter for diverse in situ tissue therapy
US5403311A (en) 1993-03-29 1995-04-04 Boston Scientific Corporation Electro-coagulation and ablation and other electrotherapeutic treatments of body tissue
US5417687A (en) 1993-04-30 1995-05-23 Medical Scientific, Inc. Bipolar electrosurgical trocar
US5405346A (en) 1993-05-14 1995-04-11 Fidus Medical Technology Corporation Tunable microwave ablation catheter
AU686173B2 (en) 1993-06-10 1998-02-05 Mir A. Imran Transurethral radio frequency ablation apparatus
JP3221184B2 (en) 1993-10-13 2001-10-22 株式会社日立製作所 Failure diagnosis apparatus and method
US5545193A (en) 1993-10-15 1996-08-13 Ep Technologies, Inc. Helically wound radio-frequency emitting electrodes for creating lesions in body tissue
US5472441A (en) 1993-11-08 1995-12-05 Zomed International Device for treating cancer and non-malignant tumors and methods
US5599345A (en) 1993-11-08 1997-02-04 Zomed International, Inc. RF treatment apparatus
US5536267A (en) 1993-11-08 1996-07-16 Zomed International Multiple electrode ablation apparatus
US5458597A (en) 1993-11-08 1995-10-17 Zomed International Device for treating cancer and non-malignant tumors and methods
US5507743A (en) 1993-11-08 1996-04-16 Zomed International Coiled RF electrode treatment apparatus
US5462521A (en) 1993-12-21 1995-10-31 Angeion Corporation Fluid cooled and perfused tip for a catheter
US5437664A (en) 1994-01-18 1995-08-01 Endovascular, Inc. Apparatus and method for venous ligation
US5458596A (en) 1994-05-06 1995-10-17 Dorsal Orthopedic Corporation Method and apparatus for controlled contraction of soft tissue
US5505730A (en) 1994-06-24 1996-04-09 Stuart D. Edwards Thin layer ablation apparatus
US5609151A (en) 1994-09-08 1997-03-11 Medtronic, Inc. Method for R-F ablation
US5560358A (en) 1994-09-08 1996-10-01 Radionics, Inc. Connector design for multi-contact medical electrode
US5545171A (en) 1994-09-22 1996-08-13 Vidamed, Inc. Anastomosis catheter
US5558673A (en) 1994-09-30 1996-09-24 Vidamed, Inc. Medical probe device and method having a flexible resilient tape stylet
US5514130A (en) 1994-10-11 1996-05-07 Dorsal Med International RF apparatus for controlled depth ablation of soft tissue
US5546267A (en) 1994-12-08 1996-08-13 Illinois Tool Works Inc. Communication circuit protector
US5868740A (en) 1995-03-24 1999-02-09 Board Of Regents-Univ Of Nebraska Method for volumetric tissue ablation
US6080150A (en) * 1995-08-15 2000-06-27 Rita Medical Systems, Inc. Cell necrosis apparatus

Cited By (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6974455B2 (en) 2002-04-10 2005-12-13 Boston Scientific Scimed, Inc. Auto advancing radio frequency array
US20060095033A1 (en) * 2002-04-10 2006-05-04 Scimed Life Systems, Inc. Manually advanceable radio frequency array with tactile feel
WO2003086533A1 (en) * 2002-04-10 2003-10-23 Scimed Life Systems, Inc. Auto advancing radio frequency array
US20090299366A1 (en) * 2002-05-27 2009-12-03 Celon Ag Medical Instruments Therapy device for thermal sclerosing of body tissue
US20050228374A1 (en) * 2002-05-27 2005-10-13 Kai Desinger Therapy apparatus for thermal sclerosing of body tissue
US20070112875A1 (en) * 2004-07-15 2007-05-17 Hitachi, Ltd. Method and apparatus for hierarchical storage management based on data value and user interest
WO2007112237A3 (en) * 2006-03-24 2008-04-03 Ionatron Inc Barrier piercing electrode
US20100108352A1 (en) * 2006-03-24 2010-05-06 Ionatron, Incorporated Barrier piercing electrode
US7944674B2 (en) 2006-03-24 2011-05-17 Applied Energetics, Inc. Barrier piercing electrode
WO2007112237A2 (en) * 2006-03-24 2007-10-04 Ionatron, Inc. Barrier piercing electrode
US10736688B2 (en) 2009-11-05 2020-08-11 Stratus Medical, LLC Methods and systems for spinal radio frequency neurotomy
US20110213356A1 (en) * 2009-11-05 2011-09-01 Wright Robert E Methods and systems for spinal radio frequency neurotomy
US11806070B2 (en) 2009-11-05 2023-11-07 Stratus Medical, LLC Methods and systems for spinal radio frequency neurotomy
US10925664B2 (en) 2009-11-05 2021-02-23 Stratus Medical, LLC Methods for radio frequency neurotomy
US10966782B2 (en) 2010-05-21 2021-04-06 Stratus Medical, LLC Needles and systems for radiofrequency neurotomy
US10716618B2 (en) 2010-05-21 2020-07-21 Stratus Medical, LLC Systems and methods for tissue ablation
US10660701B2 (en) 2014-11-19 2020-05-26 Epix Therapeutics, Inc. Methods of removing heat from an electrode using thermal shunting
US10166062B2 (en) 2014-11-19 2019-01-01 Epix Therapeutics, Inc. High-resolution mapping of tissue with pacing
US11135009B2 (en) 2014-11-19 2021-10-05 Epix Therapeutics, Inc. Electrode assembly with thermal shunt member
US9522037B2 (en) 2014-11-19 2016-12-20 Advanced Cardiac Therapeutics, Inc. Treatment adjustment based on temperatures from multiple temperature sensors
US10383686B2 (en) 2014-11-19 2019-08-20 Epix Therapeutics, Inc. Ablation systems with multiple temperature sensors
US10413212B2 (en) 2014-11-19 2019-09-17 Epix Therapeutics, Inc. Methods and systems for enhanced mapping of tissue
US10499983B2 (en) 2014-11-19 2019-12-10 Epix Therapeutics, Inc. Ablation systems and methods using heat shunt networks
US11534227B2 (en) 2014-11-19 2022-12-27 Epix Therapeutics, Inc. High-resolution mapping of tissue with pacing
US9592092B2 (en) 2014-11-19 2017-03-14 Advanced Cardiac Therapeutics, Inc. Orientation determination based on temperature measurements
US9510905B2 (en) 2014-11-19 2016-12-06 Advanced Cardiac Therapeutics, Inc. Systems and methods for high-resolution mapping of tissue
US10231779B2 (en) 2014-11-19 2019-03-19 Epix Therapeutics, Inc. Ablation catheter with high-resolution electrode assembly
US11701171B2 (en) 2014-11-19 2023-07-18 Epix Therapeutics, Inc. Methods of removing heat from an electrode using thermal shunting
US11642167B2 (en) 2014-11-19 2023-05-09 Epix Therapeutics, Inc. Electrode assembly with thermal shunt member
US9522036B2 (en) 2014-11-19 2016-12-20 Advanced Cardiac Therapeutics, Inc. Ablation devices, systems and methods of using a high-resolution electrode assembly
US9517103B2 (en) 2014-11-19 2016-12-13 Advanced Cardiac Therapeutics, Inc. Medical instruments with multiple temperature sensors
US9636164B2 (en) 2015-03-25 2017-05-02 Advanced Cardiac Therapeutics, Inc. Contact sensing systems and methods
US11576714B2 (en) 2015-03-25 2023-02-14 Epix Therapeutics, Inc. Contact sensing systems and methods
US10675081B2 (en) 2015-03-25 2020-06-09 Epix Therapeutics, Inc. Contact sensing systems and methods
US11389230B2 (en) 2016-03-15 2022-07-19 Epix Therapeutics, Inc. Systems for determining catheter orientation
US11179197B2 (en) 2016-03-15 2021-11-23 Epix Therapeutics, Inc. Methods of determining catheter orientation
US9993178B2 (en) 2016-03-15 2018-06-12 Epix Therapeutics, Inc. Methods of determining catheter orientation
US11617618B2 (en) 2017-04-27 2023-04-04 Epix Therapeutics, Inc. Contact assessment between an ablation catheter and tissue
US10893903B2 (en) 2017-04-27 2021-01-19 Epix Therapeutics, Inc. Medical instruments having contact assessment features
US10888373B2 (en) 2017-04-27 2021-01-12 Epix Therapeutics, Inc. Contact assessment between an ablation catheter and tissue

Also Published As

Publication number Publication date
US6080150A (en) 2000-06-27
US6652516B1 (en) 2003-11-25

Similar Documents

Publication Publication Date Title
US6080150A (en) Cell necrosis apparatus
US6132425A (en) Cell necrosis apparatus
US5980517A (en) Cell necrosis apparatus
US5913855A (en) Multiple antenna ablation apparatus and method
US6958062B1 (en) Multiple antenna ablation apparatus and method
US5672173A (en) Multiple antenna ablation apparatus and method
US5800484A (en) Multiple antenna ablation apparatus with expanded electrodes
US5672174A (en) Multiple antenna ablation apparatus and method
US6053937A (en) Multiple electrode ablation apparatus and method with cooling element
US5728143A (en) Multiple antenna ablation apparatus and method
US6689127B1 (en) Multiple antenna ablation apparatus and method with multiple sensor feedback
US5951547A (en) Multiple antenna ablation apparatus and method
US5782827A (en) Multiple antenna ablation apparatus and method with multiple sensor feedback
US5863290A (en) Multiple antenna ablation apparatus and method
US5683384A (en) Multiple antenna ablation apparatus
US6235023B1 (en) Cell necrosis apparatus
US5928229A (en) Tumor ablation apparatus
US5925042A (en) Multiple antenna ablation apparatus and method
US5735847A (en) Multiple antenna ablation apparatus and method with cooling element
US6330478B1 (en) Cell necrosis apparatus
US6090105A (en) Multiple electrode ablation apparatus and method
EP1366725B1 (en) Multiple electrode ablation apparatus
US20080167649A1 (en) Ablation apparatus and method
US20050101950A1 (en) Multiple antenna ablation apparatus and method
WO1999022657A1 (en) Multiple antenna ablation apparatus and method

Legal Events

Date Code Title Description
AS Assignment

Owner name: RITA MEDICAL SYSTEMS, INC., CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:EDWARDS, STUART D.;REEL/FRAME:014786/0210

Effective date: 20031211

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION